TRAMP	B-protein
,	O
a	O
novel	O
apoptosis-mediating	B-protein
receptor	I-protein
with	O
sequence	O
homology	O
to	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
1	I-protein
and	O
Fas	B-protein
(	O
Apo-1/CD95	B-protein
)	O
.	O

A	O
novel	O
member	O
of	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	I-protein
TNF	I-protein
)	I-protein
receptor	I-protein
family	I-protein
,	O
designated	O
TRAMP	B-protein
,	O
has	O
been	O
identified	O
.	O

The	O
structural	O
organization	O
of	O
the	O
393	B-protein
amino	I-protein
acid	I-protein
long	I-protein
human	I-protein
TRAMP	I-protein
is	O
most	O
homologous	O
to	O
TNF	B-protein
receptor	I-protein
1	I-protein
.	O

TRAMP	B-protein
is	O
abundantly	O
expressed	O
on	O
thymocytes	B-cell_type
and	O
lymphocytes	B-cell_type
.	O

Its	O
extracellular	O
domain	O
is	O
composed	O
of	O
four	O
cysteine-rich	B-protein
domains	I-protein
,	O
and	O
the	O
cytoplasmic	B-protein
region	I-protein
contains	O
a	O
death	B-protein
domain	I-protein
known	O
to	O
signal	O
apoptosis	O
.	O

Overexpression	O
of	O
TRAMP	B-protein
leads	O
to	O
two	O
major	O
responses	O
,	O
NF-kappaB	B-protein
activation	O
and	O
apoptosis	O
.	O

TRAMP	B-protein
-induced	O
cell	O
death	O
is	O
inhibited	O
by	O
an	O
inhibitor	O
of	O
ICE-like	B-protein
proteases	I-protein
,	O
but	O
not	O
by	O
Bcl-2	B-protein
.	O

In	O
addition	O
,	O
TRAMP	B-protein
does	O
not	O
appear	O
to	O
interact	O
with	O
any	O
of	O
the	O
known	O
apoptosis-inducing	B-protein
ligands	I-protein
of	O
the	O
TNF	B-protein
family	I-protein
.	O

Immunity	NULL
,	NULL
Vol	NULL
.	NULL

6	NULL
,	NULL
79-88	NULL
,	NULL
January	NULL
,	NULL
1997	NULL
,	NULL
Copyright	NULL
©1997	NULL
by	NULL
Cell	NULL
Press	NULL
TRAMP	NULL
,	NULL
a	NULL
Novel	NULL
Apoptosis-Mediating	NULL
Receptor	NULL
with	NULL
Sequence	NULL
Homology	NULL
to	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor	NULL
1	NULL
and	NULL
Fas	NULL
(	NULL
Apo-1/CD95	NULL
)	NULL
Jean-Luc	NULL
Bodmer	NULL
,	NULL
**	NULL
Kim	NULL
Burns	NULL
,	NULL
**	NULL
Pascal	NULL
Schneider	NULL
,	NULL
**	NULL
Kay	NULL
Hofmann	NULL
,	NULL
?	NULL

Véronique	NULL
Steiner	NULL
,	NULL
**	NULL
Margot	NULL
Thome	NULL
,	NULL
**	NULL
Thierry	NULL
Bornand	NULL
,	NULL
*	NULL
Michael	NULL
Hahne	NULL
,	NULL
*	NULL
Michael	NULL
Schroter	NULL
,	NULL
*	NULL
Karin	NULL
Becker	NULL
,	NULL
*	NULL
Anne	NULL
Wilson	NULL
,	NULL
?	NULL

Lars	NULL
E.	NULL
French/	NULL
Jeffrey	NULL
L.	NULL
Browning	NULL
,	NULL
!	NULL

H.	NULL
Robson	NULL
MacDonald	NULL
,	NULL
t	NULL
and	NULL
Jiirg	NULL
Tschopp*§	NULL
*Institute	NULL
of	NULL
Biochemistry	NULL
TLudwig	NULL
Institute	NULL
of	NULL
Cancer	NULL
Research	NULL
Lausanne	NULL
Branch	NULL
University	NULL
of	NULL
Lausanne	NULL
#	NULL
+Swiss	NULL
Institute	NULL
for	NULL
Experimental	NULL
Cancer	NULL
Research	NULL
BIL	NULL
Research	NULL
Center	NULL
Chemin	NULL
des	NULL
Boveresses	NULL
155	NULL
CH-1066	NULL
Epalinges	NULL
Switzerland	NULL
§Department	NULL
of	NULL
Dermatology	NULL
University	NULL
of	NULL
Geneva	NULL
Medical	NULL
School	NULL
CH-1211	NULL
Geneva	NULL
4	NULL
Switzerland	NULL
Biogen	NULL
,	NULL
Inc.	NULL
Department	NULL
of	NULL
Immunology	NULL
and	NULL
Inflammation	NULL
14	NULL
Cambridge	NULL
Center	NULL
Cambridge	NULL
,	NULL
Massachusetts	NULL
02142	NULL
Summary	NULL
A	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
family	NULL
,	NULL
designated	NULL
TRAMP	NULL
,	NULL
has	NULL
been	NULL
identi-fied	NULL
.	NULL

The	NULL
structural	NULL
organization	NULL
of	NULL
the	NULL
393	NULL
amino	NULL
acid	NULL
long	NULL
human	NULL
TRAMP	NULL
is	NULL
most	NULL
homologous	NULL
to	NULL
TNF	NULL
receptor	NULL
1	NULL
.	NULL

TRAMP	NULL
is	NULL
abundantly	NULL
expressed	NULL
on	NULL
thymocytes	NULL
and	NULL
lymphocytes	NULL
.	NULL

Its	NULL
extracellular	NULL
domain	NULL
is	NULL
composed	NULL
of	NULL
four	NULL
cysteine-rich	NULL
domains	NULL
,	NULL
and	NULL
the	NULL
cytoplasmic	NULL
region	NULL
contains	NULL
a	NULL
death	NULL
domain	NULL
known	NULL
to	NULL
signal	NULL
apoptosis	NULL
.	NULL

Overexpression	NULL
of	NULL
TRAMP	NULL
leads	NULL
to	NULL
two	NULL
major	NULL
responses	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
apoptosis	NULL
.	NULL

TRAMP-induced	NULL
cell	NULL
death	NULL
is	NULL
inhibited	NULL
by	NULL
an	NULL
inhibitor	NULL
of	NULL
ICE-like	NULL
proteases	NULL
,	NULL
but	NULL
not	NULL
by	NULL
Bel-2	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TRAMP	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
interact	NULL
with	NULL
any	NULL
of	NULL
the	NULL
known	NULL
apoptosis-inducing	NULL
ligands	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
.	NULL

Introduction	NULL
The	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-related	NULL
cytokines	NULL
have	NULL
emerged	NULL
over	NULL
recent	NULL
years	NULL
as	NULL
a	NULL
large	NULL
family	NULL
of	NULL
pleiotropic	NULL
mediators	NULL
of	NULL
host	NULL
defense	NULL
and	NULL
immune	NULL
regulation	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
parallel	NULL
family	NULL
of	NULL
receptors	NULL
mediates	NULL
the	NULL
initiation	NULL
of	NULL
,	NULL
among	NULL
other	NULL
things	NULL
,	NULL
cell	NULL
death	NULL
,	NULL
proliferation	NULL
,	NULL
anti-viral	NULL
activities	NULL
,	NULL
and	NULL
differentiation	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Ware	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

In	NULL
mammals	NULL
,	NULL
ten	NULL
receptors	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
NGFR	NULL
,	NULL
TNF	NULL
receptor	NULL
1	NULL
(	NULL
TNFR1	NULL
)	NULL
,	NULL
TNFR2	NULL
,	NULL
LTBR	NULL
,	NULL
CD40	NULL
,	NULL
CD30	NULL
,	NULL
CD27	NULL
,	NULL
4-1BB	NULL
,	NULL
OX	NULL
40	NULL
,	NULL
and	NULL
(	NULL
CD95	NULL
)	NULL
,	NULL
which	NULL
can	NULL
interact	NULL
with	NULL
some	NULL
eight	NULL
TNF-related	NULL
ligands	NULL
.	NULL

*These	NULL
authors	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

The	NULL
receptor	NULL
members	NULL
of	NULL
this	NULL
family	NULL
are	NULL
type	NULL
I	NULL
membrane	NULL
molecules	NULL
and	NULL
are	NULL
structurally	NULL
homologous	NULL
:	NULL
each	NULL
contains	NULL
in	NULL
its	NULL
extracellular	NULL
domain	NULL
three	NULL
to	NULL
six	NULL
imperfect	NULL
repeats	NULL
of	NULL
approximately	NULL
40	NULL
residues	NULL
,	NULL
each	NULL
containing	NULL
approximately	NULL
six	NULL
cysteines	NULL
(	NULL
Ware	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

A	NULL
single	NULL
domain	NULL
is	NULL
formed	NULL
by	NULL
six	NULL
B-sheets	NULL
in	NULL
which	NULL
the	NULL
cysteines	NULL
are	NULL
arranged	NULL
in	NULL
a	NULL
typical	NULL
1-3	NULL
,	NULL
2-4	NULL
,	NULL
5-6	NULL
pattern	NULL
(	NULL
Banner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domains	NULL
generally	NULL
lack	NULL
sequence	NULL
homology	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
motif	NULL
called	NULL
the	NULL
``	NULL
death	NULL
domain	NULL
``	NULL
found	NULL
in	NULL
TNFR1	NULL
and	NULL
Fas	NULL
(	NULL
Feinstein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Hofmann	NULL
and	NULL
Tschopp	NULL
,	NULL
1995	NULL
;	NULL
Tartaglia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
;	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
199223	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
receptors	NULL
efficiently	NULL
transmit	NULL
death	NULL
signals	NULL
,	NULL
initiated	NULL
through	NULL
association	NULL
of	NULL
TNFR1-associated	NULL
death	NULL
domain	NULL
protein	NULL
(	NULL
TRADD	NULL
)	NULL
and	NULL
Fas-associating	NULL
protein	NULL
with	NULL
death	NULL
domain	NULL
(	NULL
FADD	NULL
)	NULL
(	NULL
Boldin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995b	NULL
;	NULL
Chinnaiyan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
connect	NULL
the	NULL
receptors	NULL
to	NULL
interleukin-1B-converting	NULL
enzyme	NULL
(	NULL
ICE	NULL
)	NULL
-like	NULL
cysteine	NULL
proteases	NULL
via	NULL
FLICE/MACH	NULL
(	NULL
Boldin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
aspartate-specific	NULL
proteases	NULL
are	NULL
implicated	NULL
as	NULL
mediators	NULL
of	NULL
most	NULL
types	NULL
of	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
Dixit	NULL
,	NULL
1996	NULL
;	NULL
Henkart	NULL
,	NULL
1996	NULL
;	NULL
Kumar	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
ligand	NULL
members	NULL
are	NULL
type	NULL
II	NULL
membrane	NULL
molecules	NULL
.	NULL

Their	NULL
extracellular	NULL
domains	NULL
have	NULL
B	NULL
jelly-roll	NULL
topography	NULL
(	NULL
Banner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
are	NULL
important	NULL
in	NULL
ligand	NULL
trimeri-zation	NULL
.	NULL

Intrinsic	NULL
to	NULL
oligomerization	NULL
is	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
receptor-binding	NULL
site	NULL
at	NULL
the	NULL
junction	NULL
between	NULL
neighboring	NULL
subunits	NULL
creating	NULL
a	NULL
multivalent	NULL
ligand	NULL
.	NULL

The	NULL
binding	NULL
of	NULL
the	NULL
ligands	NULL
to	NULL
their	NULL
respective	NULL
receptors	NULL
induces	NULL
oligomerization	NULL
initiating	NULL
downstream	NULL
signaling	NULL
events	NULL
.	NULL

Except	NULL
for	NULL
the	NULL
recently	NULL
described	NULL
ligand	NULL
TRAIL	NULL
(	NULL
for	NULL
TNF-related	NULL
apoptosis-inducing	NULL
ligand	NULL
)	NULL
(	NULL
Pitti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Wiley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
receptors	NULL
have	NULL
been	NULL
identified	NULL
for	NULL
all	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
ligand	NULL
family	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
Fas	NULL
ligand	NULL
(	NULL
FasL	NULL
)	NULL
,	NULL
recombinant	NULL
TRAIL	NULL
can	NULL
induce	NULL
cell	NULL
death	NULL
in	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
cells	NULL
(	NULL
Wiley	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
corresponding	NULL
receptor	NULL
may	NULL
show	NULL
sequence	NULL
homology	NULL
to	NULL
receptors	NULL
known	NULL
to	NULL
induce	NULL
apoptosis	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
Fas	NULL
and	NULL
TNFR1	NULL
.	NULL

There-fore	NULL
,	NULL
we	NULL
have	NULL
screened	NULL
public	NULL
databases	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
such	NULL
a	NULL
molecule	NULL
and	NULL
report	NULL
here	NULL
the	NULL
characterization	NULL
of	NULL
a	NULL
novel	NULL
receptor	NULL
displaying	NULL
highest	NULL
sequence	NULL
homology	NULL
with	NULL
TNFR1	NULL
.	NULL

We	NULL
show	NULL
that	NULL
this	NULL
receptor	NULL
,	NULL
coined	NULL
TRAMP	NULL
,	NULL
can	NULL
elicit	NULL
biological	NULL
activities	NULL
similar	NULL
to	NULL
those	NULL
described	NULL
for	NULL
TNFR1	NULL
(	NULL
Tartaglia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
,	NULL
ranging	NULL
from	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

However	NULL
,	NULL
TRAMP	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
cognate	NULL
receptor	NULL
of	NULL
TRAIL	NULL
or	NULL
any	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
ligand	NULL
family	NULL
known	NULL
to	NULL
trigger	NULL
cell	NULL
death	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
TRAMP	NULL
We	NULL
reasoned	NULL
that	NULL
the	NULL
receptor	NULL
interacting	NULL
with	NULL
TRAIL	NULL
most	NULL
likely	NULL
contains	NULL
the	NULL
typical	NULL
TNF	NULL
receptor	NULL
cysteine-rich	NULL
domain	NULL
and	NULL
searched	NULL
the	NULL
dbEST	NULL
database	NULL
using	NULL
an	NULL
improved	NULL
profile	NULL
search	NULL
(	NULL
Bucher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
based	NULL
on	NULL
an	NULL
optimal	NULL
alignment	NULL
of	NULL
all	NULL
family	NULL
members	NULL
.	NULL

Five	NULL
candidate	NULL
cDNA	NULL
clones	NULL
were	NULL
found	NULL
,	NULL
four	NULL
expressed	NULL
in	NULL
Immunity	NULL
80	NULL
TRAMP	NULL
Ally	NULL
a	NULL
ak	NULL
k	NULL
e	NULL
a	NULL
kk	NULL
e	NULL
a	NULL
a	NULL
k	NULL
e	NULL
ea	NULL
ees	NULL
gece	NULL
[	NULL
1	NULL
]	NULL
o_	NULL
]	NULL
I	NULL
U	NULL
I	NULL
s	NULL
PRD	NULL
C	NULL
A	NULL
GDF	NULL
KIEL	NULL
R	NULL
c	NULL
a	NULL
AP	NULL
EHIC	NULL
GN	NULL
ST	NULL
V	NULL
Inf	NULL
TNFRL	NULL
1	NULL
YP	NULL
I	NULL
GLV	NULL
PHL	NULL
GWIRE	NULL
.	NULL

...	NULL
..	NULL
..	NULL
KLgD	NULL
S	NULL
ip	NULL
ifo	NULL
K	NULL
YI	NULL
L	NULL
@	NULL
P	NULL
Q	NULL
NN	NULL
S	NULL
I	NULL
K	NULL
K	NULL
N	NULL
p	NULL
6	NULL
o	NULL
D	NULL
T	NULL
R	NULL
E	NULL
(	NULL
of	NULL
FAS	NULL
RL	NULL
@	NULL
IS	NULL
.	NULL

KSVNAQVTRBIINSKGLELREK	NULL
TT	NULL
ET'NLEGLHHDEQ	NULL
E	NULL
K	NULL
P	NULL
P	NULL
gE	NULL
RK	NULL
AR	NULL
N	NULL
gD	NULL
E	NULL
P	NULL
P	NULL
of	NULL
i	NULL
-	NULL
[	NULL
CT	NULL
}	NULL
t	NULL
[	NULL
77	NULL
|	NULL
Lw_	NULL
]	NULL
TRAMP	NULL
50	NULL
poprtgh	NULL
z	NULL
n	NULL
Giz	NULL
Sa	NULL
Cisco	NULL
a	NULL
oa	NULL
s	NULL
(	NULL
a	NULL
zm	NULL
s	NULL
a	NULL
v	NULL
a	NULL
gees	NULL
»	NULL
divs	NULL
do	NULL
v	NULL
s	NULL
o	NULL
div	NULL
s	NULL
ss	NULL
»	NULL
y	NULL
do	NULL
t	NULL
p	NULL
TNFRL	NULL
63	NULL
s	NULL
n	NULL
.	NULL

R	NULL
nisku	NULL
s	NULL
(	NULL
ails	NULL
x	NULL
Sir	NULL
K	NULL
mM	NULL
EI	NULL
s	NULL
s	NULL
p	NULL
R	NULL
cok	NULL
x	NULL
So	NULL
van	NULL
ywGlen	NULL
L	NULL
..	NULL
...	NULL
Glo	NULL
F	NULL
Nis	NULL
L	NULL
FAS	NULL
70	NULL
or	NULL
gik	NULL
ey	NULL
n	NULL
o	NULL
K	NULL
Abir	NULL
s	NULL
Gix	NULL
Sin	NULL
Cale	NULL
c	NULL
a	NULL
gu	NULL
eve	NULL
I	NULL
|	NULL
r	NULL
r	NULL
o	NULL
N	NULL
c	NULL
oor	NULL
e..	NULL
--	NULL
-	NULL
.	NULL

s	NULL
ngo	NULL
K	NULL
}	NULL
5	NULL
l	NULL
HrSTOP—_|	NULL
TRaMp	NULL
|	NULL
120	NULL
TR	NULL
is	NULL
.	NULL

RRD	NULL
gn	NULL
L	NULL
...	NULL
.	NULL

TNFRL	NULL
_	NULL
127	NULL
.	NULL

.	NULL

ive	NULL
ty	NULL
®	NULL
ifs	NULL
slo	NULL
s	NULL
ko	NULL
.	NULL

igh	NULL
a	NULL
gigi	NULL
c	NULL
re	NULL
s	NULL
.	NULL

...	NULL
sn	NULL
kk	NULL
sn	NULL
raft	NULL
kn	NULL
gn	NULL
ENVKGTEDSGT	NULL
Fas	NULL
133	NULL
g	NULL
...	NULL
»	NULL
KEEGS	NULL
REN	NULL
...	NULL
..	NULL
..	NULL
.	NULL

.	NULL

2	NULL
kk	NULL
kk	NULL
kkk	NULL
e	NULL
k	NULL
aka	NULL
e	NULL
e	NULL
k	NULL
k	NULL
k	NULL
ek	NULL
ek	NULL
a	NULL
a	NULL
kes	NULL
I	NULL
T	NULL
I	NULL
TRAMP	NULL
-	NULL
161	NULL
v1	NULL
@	NULL
a	NULL
gy	NULL
?	NULL

car	NULL
@	NULL
ryry	NULL
...	NULL
.	NULL

@	NULL
uc	NULL
.	NULL

Q.	NULL
palans	NULL
DSAHTLLAPEESS	NULL
TNFRL	NULL
18	NULL
9	NULL
tv	NULL
@	NULL
i	NULL
@	NULL
jei®	NULL
@	NULL
@	NULL
t	NULL
rre	NULL
Micuns	NULL
nor	NULL
Ie	NULL
uw	NULL
y	NULL
or	NULL
(	NULL
ids	NULL
Sox	NULL
s	NULL
I	NULL
v	NULL
is	NULL
t	NULL
o	NULL
aik	NULL
&	NULL
Ole	NULL
1	NULL
.	NULL

TK	NULL
PNPS	NULL
F	NULL
SPT	NULL
EPT	NULL
FAs	NULL
15s	NULL
...	NULL
pI	NULL
PE	NULL
vw	NULL
v.	NULL
l	NULL
ul	NULL
lll	NULL
ls	NULL
a	NULL
ge	NULL
v	NULL
ok	NULL
j	NULL
R	NULL
x	NULL
fain	NULL
a	NULL
(	NULL
ele	NULL
MB	NULL
]	NULL
.	NULL

2	NULL
0	NULL
2	NULL
222	NULL
n	NULL
n	NULL
ss	NULL
e	NULL
n	NULL
eee	NULL
ee	NULL
e	NULL
>	NULL
TRAMP	NULL
245	NULL
ude	NULL
ar..	NULL
pgs	NULL
Ags	NULL
ees	NULL
rawm	NULL
bor	NULL
.	NULL

...	NULL
.	NULL

TNFRL	NULL
-	NULL
259	NULL
FAAPRREVAPPYo	NULL
@	NULL
aA	NULL
o	NULL
AWasbrIpNpMorw®DpsakXk	NULL
Po	NULL
FAS	NULL
49	NULL
60.2	NULL
.k	NULL
kk	NULL
k	NULL
k	NULL
k	NULL
k	NULL
a	NULL
dos	NULL
n	NULL
n	NULL
a	NULL
n	NULL
n	NULL
do	NULL
a	NULL
n	NULL
g	NULL
d	NULL
n	NULL
n	NULL
t	NULL
n	NULL
s	NULL
n	NULL
d	NULL
d	NULL
n	NULL
n	NULL
s	NULL
s	NULL
nok	NULL
son	NULL
n	NULL
ene	NULL
s	NULL
bn	NULL
...	NULL
...	NULL
i	NULL
LEE—17	NULL
TRAMP	NULL
-	NULL
308	NULL
...	NULL
...	NULL
a	NULL
p	NULL
o	NULL
Pein	NULL
tx	NULL
pa	NULL
bls	NULL
w	NULL
KE	NULL
rVR	NULL
chiesa	NULL
vigy	NULL
s	NULL
I	NULL
.	NULL

r	NULL
do	NULL
(	NULL
eds	NULL
r	NULL
Arle	NULL
oGa	NULL
cue	NULL
.	NULL

..	NULL
TNFRL	NULL
-	NULL
328	NULL
SLDTDDPAT	NULL
a	NULL
wok	NULL
s	NULL
ry	NULL
®	NULL
g	NULL
s	NULL
p	NULL
x	NULL
salir	NULL
1	NULL
gt	NULL
o	NULL
c	NULL
1	NULL
digga	NULL
Seals	NULL
Sida	NULL
r	NULL
Acar	NULL
t	NULL
gin	NULL
r	NULL
L	NULL
E	NULL
ras	NULL
214	NULL
...	NULL
...	NULL
8	NULL
KY	NULL
LT	NULL
T	NULL
I	NULL
A	NULL
Gv	NULL
MT	NULL
L	NULL
s	NULL
q	NULL
v	NULL
file	NULL
caulk	NULL
n	NULL
Sv	NULL
v	NULL
Gix	NULL
alle	NULL
1	NULL
kn	NULL
o	NULL
gfv	NULL
o	NULL
o	NULL
T	NULL
a	NULL
pifelk	NULL
v	NULL
o	NULL
1	NULL
fs	NULL
n	NULL
pfu	NULL
fo	NULL
x	NULL
c	NULL
x	NULL
Kise	NULL
]	NULL
.	NULL

xb	NULL
a	NULL
9	NULL
3	NULL
TRAMP	NULL
-	NULL
368	NULL
av	NULL
R	NULL
SREQRGP	NULL
.	NULL

...	NULL
...	NULL
...	NULL
.k	NULL
e.	NULL
es	NULL
TNFRL	NULL
3	NULL
9	NULL
8	NULL
~	NULL
1	NULL
Mo	NULL
r	NULL
visa	NULL
o	NULL
foi	NULL
#	NULL
lL	NULL
Eagiceraaunrrarguno§	NULL
.	NULL

l.	NULL
l	NULL
...	NULL
FaS	NULL
277.	NULL
om	NULL
fft	NULL
k	NULL
ofx	NULL
K	NULL
a	NULL
Nifjo	NULL
TL	NULL
Apfk	NULL
jo	NULL
TI	NULL
I	NULL
LKDTIT	NULL
S	NULL
DSE	NULL
NGN	NULL
FE	NULL
EI	NULL
Qs	NULL
LV	NULL
Figure	NULL
1	NULL
.	NULL

Predicted	NULL
Amino	NULL
Acid	NULL
Sequence	NULL
of	NULL
TRAMP	NULL
and	NULL
Its	NULL
Homology	NULL
to	NULL
Fas	NULL
and	NULL
TNFR1	NULL
Colinear	NULL
amino	NULL
acid	NULL
sequence	NULL
alignment	NULL
of	NULL
human	NULL
TRAMP	NULL
,	NULL
TNFR1	NULL
,	NULL
and	NULL
Fas	NULL
.	NULL

Sequence	NULL
numbering	NULL
starts	NULL
at	NULL
the	NULL
N-terminus	NULL
of	NULL
the	NULL
predicted	NULL
mature	NULL
protein	NULL
.	NULL

The	NULL
cysteine-rich	NULL
domains	NULL
(	NULL
I-IV	NULL
)	NULL
,	NULL
the	NULL
predicted	NULL
transmembrane	NULL
segment	NULL
{	NULL
(	NULL
TM	NULL
)	NULL
,	NULL
and	NULL
the	NULL
death	NULL
domain	NULL
(	NULL
DD	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
C-terminus	NULL
of	NULL
the	NULL
alternatively	NULL
spliced	NULL
form	NULL
giving	NULL
rise	NULL
to	NULL
the	NULL
soluble	NULL
form	NULL
of	NULL
TRAMP	NULL
is	NULL
marked	NULL
with	NULL
an	NULL
arrow	NULL
(	NULL
stop	NULL
)	NULL
.	NULL

In	NULL
the	NULL
four	NULL
clones	NULL
coding	NULL
for	NULL
the	NULL
short	NULL
version	NULL
of	NULL
TRAMP	NULL
,	NULL
the	NULL
leucine	NULL
was	NULL
replaced	NULL
by	NULL
a	NULL
proline	NULL
at	NULL
position	NULL
143	NULL
.	NULL

Identical	NULL
and	NULL
similar	NULL
residues	NULL
are	NULL
represented	NULL
in	NULL
closed	NULL
and	NULL
shaded	NULL
boxes	NULL
,	NULL
respectively	NULL
.	NULL

a	NULL
brain	NULL
cDNA	NULL
library	NULL
and	NULL
one	NULL
in	NULL
a	NULL
fetal	NULL
lung	NULL
cDNA	NULL
library	NULL
.	NULL

Sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
5'-end	NULL
sequences	NULL
of	NULL
the	NULL
clones	NULL
were	NULL
identical	NULL
.	NULL

The	NULL
four	NULL
shorter	NULL
clones	NULL
predicted	NULL
a	NULL
soluble	NULL
receptor	NULL
that	NULL
consisted	NULL
of	NULL
three	NULL
and	NULL
a	NULL
half	NULL
cysteine	NULL
repeat	NULL
units	NULL
with	NULL
a	NULL
stop	NULL
codon	NULL
after	NULL
157	NULL
amino	NULL
acids	NULL
,	NULL
with	NULL
no	NULL
indication	NULL
of	NULL
a	NULL
hydrophobic	NULL
transmembrane	NULL
region	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
longer	NULL
clone	NULL
(	NULL
1.7	NULL
kb	NULL
)	NULL
contained	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
capable	NULL
of	NULL
coding	NULL
a	NULL
sequence	NULL
of	NULL
393	NULL
amino	NULL
acids	NULL
for	NULL
the	NULL
mature	NULL
protein	NULL
,	NULL
preceded	NULL
by	NULL
hydrophobic	NULL
amino	NULL
acids	NULL
typical	NULL
of	NULL
a	NULL
signal	NULL
peptide	NULL
.	NULL

The	NULL
predicted	NULL
extracellular	NULL
domain	NULL
included	NULL
four	NULL
complete	NULL
TNFR	NULL
folds	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
putative	NULL
transmembrane	NULL
segment	NULL
and	NULL
a	NULL
193	NULL
amino	NULL
acid	NULL
long	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
region	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
death	NULL
domain	NULL
previously	NULL
found	NULL
to	NULL
be	NULL
important	NULL
in	NULL
signaling	NULL
cell	NULL
death	NULL
(	NULL
Itoh	NULL
and	NULL
Nagata	NULL
,	NULL
1993	NULL
;	NULL
Tartaglia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
was	NULL
detected	NULL
close	NULL
to	NULL
the	NULL
C-terminus	NULL
.	NULL

The	NULL
overall	NULL
sequence	NULL
of	NULL
this	NULL
novel	NULL
receptor	NULL
,	NULL
which	NULL
we	NULL
designate	NULL
TRAMP	NULL
(	NULL
for	NULL
TNF	NULL
receptor-related	NULL
apoptosis-mediating	NULL
protein	NULL
)	NULL
is	NULL
most	NULL
similar	NULL
to	NULL
TNFR1	NULL
(	NULL
22.5	NULL
%	NULL
identical	NULL
residues	NULL
)	NULL
,	NULL
followed	NULL
by	NULL
Fas	NULL
(	NULL
14	NULL
%	NULL
;	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Highest	NULL
sequence	NULL
similarity	NULL
was	NULL
found	NULL
in	NULL
the	NULL
region	NULL
of	NULL
the	NULL
death	NULL
domain	NULL
,	NULL
in	NULL
which	NULL
40	NULL
%	NULL
of	NULL
the	NULL
residues	NULL
are	NULL
identical	NULL
between	NULL
TRAMP	NULL
and	NULL
TNFR1	NULL
.	NULL

Expression	NULL
of	NULL
TRAMP	NULL
The	NULL
expression	NULL
of	NULL
TRAMP	NULL
was	NULL
studied	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

A	NULL
transcript	NULL
of	NULL
3.2	NULL
kb	NULL
was	NULL
detected	NULL
in	NULL
lymphocyte-rich	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
thymus	NULL
,	NULL
colon	NULL
,	NULL
intestine	NULL
,	NULL
and	NULL
spleen	NULL
.	NULL

TRAMP	NULL
mRNA	NULL
was	NULL
also	NULL
found	NULL
in	NULL
the	NULL
prostate	NULL
,	NULL
whereas	NULL
other	NULL
tissues	NULL
tested	NULL
were	NULL
neg-ative	NULL
.	NULL

TRAMP	NULL
expression	NULL
within	NULL
organs	NULL
was	NULL
studied	NULL
in	NULL
more	NULL
detail	NULL
in	NULL
mice	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

In	NULL
bone	NULL
marrow	NULL
,	NULL
the	NULL
transcript	NULL
size	NULL
heterogeneity	NULL
was	NULL
considerable	NULL
as	NULL
four	NULL
prominent	NULL
cross-hybridizing	NULL
mRNAs	NULL
were	NULL
detectable	NULL
migrating	NULL
at	NULL
approximately	NULL
1.0	NULL
,	NULL
1.6	NULL
,	NULL
3.4	NULL
,	NULL
and	NULL
4.5	NULL
kb	NULL
.	NULL

The	NULL
1.0	NULL
kb	NULL
was	NULL
the	NULL
major	NULL
transcript	NULL
detected	NULL
in	NULL
stromal	NULL
cells	NULL
of	NULL
the	NULL
spleen	NULL
.	NULL

Purified	NULL
splenocytes	NULL
,	NULL
however	NULL
,	NULL
expressed	NULL
mostly	NULL
the	NULL
1.6	NULL
kb	NULL
and	NULL
4.8	NULL
kb	NULL
message	NULL
.	NULL

In	NULL
thymocytes	NULL
,	NULL
the	NULL
larger	NULL
transcript	NULL
(	NULL
s	NULL
)	NULL
was	NULL
most	NULL
abundantly	NULL
expressed	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
1.0	NULL
kb	NULL
message	NULL
was	NULL
selectively	NULL
up-regulated	NULL
in	NULL
Fas-deficient	NULL
Ipr	NULL
mice	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
TRAMP	NULL
Protein	NULL
In	NULL
agreement	NULL
with	NULL
the	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
highest	NULL
levels	NULL
of	NULL
the	NULL
TRAMP	NULL
protein	NULL
were	NULL
found	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Polyclonal	NULL
antibodies	NULL
generated	NULL
against	NULL
the	NULL
N-terminal	NULL
sequence	NULL
of	NULL
TRAMP	NULL
reacted	NULL
with	NULL
a	NULL
protein	NULL
of	NULL
approximately	NULL
56	NULL
kDa	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
size	NULL
of	NULL
recombinant	NULL
TRAMP	NULL
overexpressed	NULL
in	NULL
29317	NULL
cells	NULL
,	NULL
present	NULL
in	NULL
various	NULL
human	NULL
cell	NULL
lines	NULL
of	NULL
epithelial	NULL
,	NULL
neu-ronal	NULL
,	NULL
and	NULL
lymphocytic	NULL
origin	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
the	NULL
related	NULL
Fas	NULL
and	NULL
TNF	NULL
receptors	NULL
,	NULL
TRAMP	NULL
is	NULL
most	NULL
likely	NULL
glycosylated	NULL
,	NULL
as	NULL
the	NULL
predicted	NULL
molecular	NULL
mass	NULL
is	NULL
42.9	NULL
kDa	NULL
.	NULL

Differences	NULL
in	NULL
glycosylation	NULL
may	NULL
also	NULL
explain	NULL
the	NULL
variations	NULL
and	NULL
heterogeneity	NULL
of	NULL
the	NULL
molecular	NULL
size	NULL
among	NULL
different	NULL
cells	NULL
.	NULL

In	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
,	NULL
for	NULL
example	NULL
,	NULL
bands	NULL
of	NULL
56	NULL
and	NULL
53	NULL
kDa	NULL
were	NULL
seen	NULL
,	NULL
while	NULL
in	NULL
melanoma	NULL
cell	NULL
lines	NULL
and	NULL
U937	NULL
,	NULL
proteins	NULL
of	NULL
56	NULL
and	NULL
59	NULL
kDa	NULL
were	NULL
detectable	NULL
,	NULL
respectively	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
TRAMP	NULL
expression	NULL
in	NULL
PBLs	NULL
declined	NULL
after	NULL
prolonged	NULL
stimulation	NULL
with	NULL
the	NULL
lectin	NULL
PHA	NULL
and	NULL
interleukin-2	NULL
.	NULL

TRAMP	NULL
Activates	NULL
NF-	NULL
«	NULL
B	NULL
An	NULL
important	NULL
response	NULL
induced	NULL
by	NULL
TNFR1	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
initiated	NULL
by	NULL
the	NULL
oligomerization	NULL
of	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
TRAMP	NULL
,	NULL
an	NULL
Apoptosis-Signaling	NULL
Receptor	NULL
81	NULL
A	NULL
HC	NULL
5510	NULL
$	NULL
09	NULL
,	NULL
a	NULL
x	NULL
6623	NULL
«	NULL
$	NULL
&	NULL
0°	NULL
CS	NULL
»	NULL
.s	NULL
6	NULL
&	NULL
0	NULL
&	NULL
«	NULL
Q	NULL
»	NULL
&	NULL
.s	NULL
8.8	NULL
so	NULL
CEs	NULL
F	NULL
SSCA	NULL
$	NULL
«	NULL
$	NULL
on	NULL
$	NULL
&	NULL
$	NULL
&	NULL
4.4	NULL
-	NULL
'	NULL
E	NULL
#	NULL
24	NULL
1.3	NULL
o	NULL
af	NULL
B	NULL
00434	NULL
4°	NULL
ad	NULL
©	NULL
C	NULL
oa	NULL
y	NULL
©	NULL
0	NULL
6	NULL
$	NULL
@	NULL
%	NULL
Q\	NULL
&	NULL
f	NULL
©	NULL
.C	NULL
&	NULL
``	NULL
$	NULL
2	NULL
[	NULL
&	NULL
8	NULL
S	NULL
&	NULL
C	NULL
&	NULL
C	NULL
&	NULL
©	NULL
.C	NULL
3	NULL
$	NULL
of	NULL
&	NULL
&	NULL
1.8-1.8-	NULL
aas	NULL
Figure	NULL
2	NULL
.	NULL

TRAMP	NULL
Is	NULL
Expressed	NULL
in	NULL
Lymphocyte-Rich	NULL
Tissues	NULL
{	NULL
A	NULL
)	NULL
Norther	NULL
blot	NULL
analysis	NULL
of	NULL
poly	NULL
{	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
2	NULL
g	NULL
per	NULL
lane	NULL
}	NULL
of	NULL
various	NULL
human	NULL
tissues	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Northen	NULL
blot	NULL
analysis	NULL
of	NULL
mouse	NULL
bone	NULL
marrow	NULL
,	NULL
splenocytes	NULL
,	NULL
and	NULL
remaining	NULL
splenic	NULL
stromal	NULL
cells	NULL
after	NULL
splenocyte	NULL
removal	NULL
{	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
right	NULL
panel	NULL
shows	NULL
TRAMP	NULL
transcripts	NULL
in	NULL
thymocytes	NULL
from	NULL
wild-type	NULL
and	NULL
Fas-deficient	NULL
Ipr/lipr	NULL
mutant	NULL
mice	NULL
.	NULL

Blots	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
probe	NULL
corresponding	NULL
to	NULL
the	NULL
extracellular	NULL
region	NULL
of	NULL
human	NULL
TRAMP	NULL
.	NULL

TNFR1	NULL
upon	NULL
ligand	NULL
binding	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
TRADD	NULL
.	NULL

To	NULL
investigate	NULL
a	NULL
possible	NULL
activation	NULL
of	NULL
the	NULL
signaling	NULL
pathway	NULL
leading	NULL
to	NULL
NF-kB	NULL
activation	NULL
,	NULL
we	NULL
transiently	NULL
transfected	NULL
2931	NULL
cells	NULL
with	NULL
a	NULL
TNF	NULL
promoter-derived	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
gene	NULL
and	NULL
increasing	NULL
amounts	NULL
of	NULL
the	NULL
TRAMP	NULL
expression	NULL
vector	NULL
.	NULL

TRAMP	NULL
expression	NULL
strongly	NULL
induced	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
in	NULL
a	NULL
dose-dependent	NULL
fashion	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
inhibitor	NULL
of	NULL
apoptosis	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
an	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
of	NULL
up	NULL
to	NULL
25-fold	NULL
was	NULL
measured	NULL
.	NULL

200	NULL
150	NULL
100	NULL
Relative	NULL
Luciferase	NULL
Activity	NULL
fu	NULL
l=	NULL
]	NULL
0	NULL
0.05	NULL
0.25	NULL
1	NULL
TRAMP	NULL
DNA	NULL
(	NULL
ug	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

Transcription	NULL
Factor	NULL
NF-	NULL
«	NULL
B	NULL
Is	NULL
Activated	NULL
by	NULL
TRAMP	NULL
Effect	NULL
of	NULL
increasing	NULL
TRAMP	NULL
expression	NULL
on	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
293T	NULL
cells	NULL
,	NULL
determined	NULL
by	NULL
a	NULL
TNF	NULL
promoter-derived	NULL
NF-xB-luciferasegene	NULL
reporter	NULL
assay	NULL
.	NULL

TRAMP	NULL
Signals	NULL
Apoptosis	NULL
The	NULL
second	NULL
signaling	NULL
pathway	NULL
triggered	NULL
by	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
TNFR1	NULL
(	NULL
and	NULL
Fas	NULL
)	NULL
is	NULL
that	NULL
leading	NULL
to	NULL
apoptosis	NULL
.	NULL

To	NULL
investigate	NULL
a	NULL
possible	NULL
role	NULL
of	NULL
TRAMP	NULL
in	NULL
apoptosis	NULL
,	NULL
we	NULL
transiently	NULL
overexpressed	NULL
TRAMP	NULL
in	NULL
293T	NULL
cells	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
transfected	NULL
cells	NULL
abundantly	NULL
expressed	NULL
TRAMP	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

When	NULL
their	NULL
morphology	NULL
was	NULL
examined	NULL
by	NULL
phase-contrast	NULL
microscopy	NULL
24	NULL
hr	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
had	NULL
rounded	NULL
up	NULL
and	NULL
had	NULL
undergone	NULL
morphological	NULL
changes	NULL
typical	NULL
of	NULL
apoptosis	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
empty	NULL
control	NULL
vector	NULL
retained	NULL
their	NULL
flat	NULL
adherent	NULL
appearance	NULL
.	NULL

Inhibitors	NULL
of	NULL
ICE-like	NULL
proteases	NULL
such	NULL
as	NULL
crmA	NULL
encoded	NULL
by	NULL
the	NULL
cowpox	NULL
virus	NULL
or	NULL
synthetic	NULL
peptides	NULL
can	NULL
block	NULL
TNF	NULL
and	NULL
FasL-induced	NULL
apoptosis	NULL
(	NULL
Los	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Tewari	NULL
and	NULL
Dixit	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

When	NULL
293T	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
TRAMP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zVAD-fmk	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
ICE-like	NULL
proteases	NULL
,	NULL
cells	NULL
retained	NULL
their	NULL
viable	NULL
appearance	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
be/-2	NULL
cDNA	NULL
(	NULL
Borner	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
with	NULL
the	NULL
TRAMP	NULL
expression	NULL
plasmid	NULL
did	NULL
not	NULL
rescue	NULL
cells	NULL
from	NULL
death	NULL
.	NULL

A	NULL
biochemical	NULL
hallmark	NULL
of	NULL
apoptosis	NULL
is	NULL
the	NULL
degradation	NULL
of	NULL
nuclear	NULL
DNA	NULL
into	NULL
oligonucleosome-sized	NULL
fragments	NULL
(	NULL
Peitsch	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Russell	NULL
,	NULL
1983	NULL
)	NULL
,	NULL
and	NULL
indeed	NULL
TRAMP-expressing	NULL
cells	NULL
had	NULL
fragmented	NULL
nuclear	NULL
DNA	NULL
Figure	NULL
3	NULL
.	NULL

TRAMP	NULL
Protein	NULL
Expression	NULL
in	NULL
Vari-	NULL
\	NULL
Cb	NULL
Q	NULL
,	NULL
X39	NULL
ip	NULL
(	NULL
0,3	NULL
?	NULL
)	NULL

(	NULL
1555	NULL
C	NULL
$	NULL
55	NULL
)	NULL
o	NULL
ous	NULL
Human	NULL
Cell	NULL
Lines	NULL
\	NULL
?	NULL

9	NULL
ab	NULL
A	NULL
2,8	NULL
X	NULL
<	NULL
a	NULL
a	NULL
«	NULL
PS	NULL
&	NULL
OC	NULL
S	NULL
A	NULL
oo	NULL
``	NULL
oF	NULL
B	NULL
.8	NULL
oF	NULL
,	NULL
,	NULL
$	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
membrane	NULL
fractions	NULL
0	NULL
NPC	NULL
6b	NULL
Q	NULL
RX	NULL
EOF	NULL
CCS	NULL
OSC	NULL
CAAC	NULL
/	NULL
of	NULL
various	NULL
human	NULL
cells	NULL
.	NULL

SH-T58	NULL
(	NULL
SK-N-SH	NULL
}	NULL
)	NULL
,	NULL
B3-	NULL
neuroblastoma	NULL
;	NULL
G215	NULL
(	NULL
LN215	NULL
)	NULL
,	NULL
glioblastoma	NULL
;	NULL
gg—	NULL
e	NULL
-	NULL
(	NULL
fue	NULL
PBLs	NULL
activated	NULL
with	NULL
PHA	NULL
and	NULL
interleukin-2	NULL
~	NULL
f	NULL
um	NULL
for	NULL
48	NULL
hr	NULL
and	NULL
120	NULL
hr	NULL
,	NULL
respectively	NULL
;	NULL
ME	NULL
260	NULL
,	NULL
32-	NULL
melanoma	NULL
;	NULL
HeLa	NULL
,	NULL
cervix	NULL
cell	NULL
line	NULL
;	NULL
SK-Me123	NULL
,	NULL
melanoma	NULL
;	NULL
HT-29	NULL
,	NULL
colon	NULL
carcinoma	NULL
;	NULL
LAN-1	NULL
,	NULL
25-	NULL
neuroblastoma	NULL
;	NULL
U937	NULL
,	NULL
monocytic	NULL
cell	NULL
line	NULL
;	NULL
293T	NULL
Rec'Fo	NULL
PBL	NULL
,	NULL
HEK293	NULL
,	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
,	NULL
Jur-	NULL
kat	NULL
,	NULL
T	NULL
cell	NULL
leukemia	NULL
;	NULL
Raji	NULL
,	NULL
B	NULL
cell	NULL
lymphoma	NULL
;	NULL
LG-2	NULL
,	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cell	NULL
.	NULL

Controls	NULL
(	NULL
right	NULL
)	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
TRAMP	NULL
cDNA	NULL
,	NULL
human	NULL
Fas	NULL
cDNA	NULL
,	NULL
and	NULL
the	NULL
empty	NULL
vector	NULL
{	NULL
mock	NULL
}	NULL
were	NULL
transfected	NULL
into	NULL
2937	NULL
cells	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
using	NULL
the	NULL
affinity-purified	NULL
polyclonal	NULL
antibody	NULL
against	NULL
TRAMP	NULL
(	NULL
AL104	NULL
)	NULL
.	NULL

The	NULL
quality	NULL
of	NULL
the	NULL
anti-TRAMP	NULL
antibody	NULL
was	NULL
also	NULL
assayed	NULL
on	NULL
TRAMP-Fc	NULL
and	NULL
human	NULL
Fas-Fc	NULL
,	NULL
respectively	NULL
(	NULL
Rec-Fc	NULL
;	NULL
1	NULL
pg	NULL
per	NULL
lane	NULL
)	NULL
.	NULL

Immunity	NULL
82	NULL
A	NULL
B	NULL
TRAMP	NULL
control	NULL
TRAMP	NULL
TRAMP+	NULL
Z-VAD-fmk	NULL
_	NULL
TRAMP	NULL
+	NULL
bel-2	NULL
control	NULL
0.75	NULL
0.5	NULL
0.25	NULL
Apoptotic	NULL
Index	NULL
(	NULL
OD	NULL
«	NULL
os	NULL
nm	NULL
)	NULL
0	NULL
Figure	NULL
5	NULL
.	NULL

Apoptosis	NULL
Induced	NULL
by	NULL
TRAMP	NULL
Overexpression	NULL
in	NULL
2937	NULL
Cells	NULL
Is	NULL
Blocked	NULL
by	NULL
an	NULL
Inhibitor	NULL
of	NULL
ICE-like	NULL
Proteases	NULL
(	NULL
A	NULL
)	NULL
Expression	NULL
of	NULL
TRAMP	NULL
in	NULL
293T	NULL
cells	NULL
12	NULL
hr	NULL
after	NULL
transient	NULL
transfection	NULL
of	NULL
TRAMP	NULL
cDNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
zVAD-fmk	NULL
(	NULL
a	NULL
broad	NULL
spectrum	NULL
inhibitor	NULL
of	NULL
ICE-like	NULL
proteases	NULL
)	NULL
.	NULL

The	NULL
smaller	NULL
panel	NULL
shows	NULL
cells	NULL
transfected	NULL
with	NULL
an	NULL
empty	NULL
control	NULL
vector	NULL
.	NULL

The	NULL
bar	NULL
is	NULL
20	NULL
jm	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Morphology	NULL
of	NULL
293T	NULL
cells	NULL
transiently	NULL
overexpressing	NULL
TRAMP	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
zZVAD-fmk	NULL
and	NULL
analyzed	NULL
24	NULL
hr	NULL
later	NULL
by	NULL
phase-contrast	NULL
microscopy	NULL
.	NULL

Bar	NULL
is	NULL
50	NULL
wm	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNA	NULL
fragmentation	NULL
of	NULL
TRAMP-transfected	NULL
cells	NULL
(	NULL
see	NULL
[	NULL
B	NULL
]	NULL
)	NULL
was	NULL
analyzed	NULL
by	NULL
the	NULL
determination	NULL
of	NULL
cytoplasmic	NULL
histone-containing	NULL
DNA	NULL
complexes	NULL
.	NULL

(	NULL
Figure	NULL
5C	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
interpretation	NULL
that	NULL
TRAMP-induced	NULL
apoptosis	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
ICE-like	NULL
proteases	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
morphological	NULL
and	NULL
biochemical	NULL
changes	NULL
typical	NULL
of	NULL
apoptosis	NULL
.	NULL

The	NULL
Death	NULL
Domain	NULL
of	NULL
TRAMP	NULL
Homo-Oligomerizes	NULL
and	NULL
Can	NULL
Recruit	NULL
FADD	NULL
The	NULL
downstream	NULL
effector	NULL
molecules	NULL
that	NULL
induce	NULL
Fas-mediated	NULL
apoptosis	NULL
are	NULL
FADD	NULL
and	NULL
FLICE	NULL
(	NULL
for	NULL
FADD-like	NULL
ICE	NULL
)	NULL
(	NULL
Boldin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Muzio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

FADD	NULL
is	NULL
a	NULL
typical	NULL
linker	NULL
protein	NULL
with	NULL
a	NULL
N-terminal	NULL
death	NULL
domain	NULL
binding	NULL
to	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
oligomerized	NULL
Fas	NULL
and	NULL
a	NULL
C-terminal	NULL
death	NULL
effector	NULL
domain	NULL
interacting	NULL
with	NULL
the	NULL
death	NULL
effector	NULL
domain	NULL
of	NULL
FLICE	NULL
.	NULL

The	NULL
C-terminus	NULL
of	NULL
FLICE	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
contains	NULL
an	NULL
ICE-like	NULL
cysteine	NULL
protease	NULL
coupling	NULL
FAS	NULL
to	NULL
the	NULL
ICE	NULL
proteases	NULL
.	NULL

This	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
whether	NULL
FADD	NULL
can	NULL
associate	NULL
with	NULL
TRAMP	NULL
.	NULL

The	NULL
Flag-tagged	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
TRAMP	NULL
(	NULL
amino	NULL
acids	NULL
197-393	NULL
)	NULL
was	NULL
cotransfected	NULL
with	NULL
a	NULL
FADD	NULL
expression	NULL
vector	NULL
in	NULL
293T	NULL
cells	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
Flag	NULL
,	NULL
TRAMP	NULL
revealed	NULL
that	NULL
FADD	NULL
associated	NULL
with	NULL
TRAMP	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
parallel	NULL
experiments	NULL
using	NULL
the	NULL
Flag-tagged	NULL
cytoplasmic	NULL
region	NULL
of	NULL
Fas	NULL
and	NULL
FADD	NULL
,	NULL
however	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
TRAMP	NULL
with	NULL
FADD	NULL
appeared	NULL
to	NULL
be	NULL
less	NULL
efficient	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
was	NULL
detectable	NULL
only	NULL
at	NULL
very	NULL
high	NULL
FADD	NULL
expression	NULL
levels	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
TRAMP	NULL
can	NULL
recruit	NULL
FADD	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
TRAMP	NULL
directly	NULL
associates	NULL
with	NULL
FADD	NULL
or	NULL
whether	NULL
TRAMP-FADD	NULL
complex	NULL
formation	NULL
is	NULL
mediated	NULL
by	NULL
(	NULL
endogenous	NULL
)	NULL
TRADD	NULL
,	NULL
as	NULL
seen	NULL
for	NULL
TNFR1	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
expression	NULL
vector	NULL
coding	NULL
for	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
TRAMP	NULL
into	NULL
293T	NULL
cells	NULL
was	NULL
also	NULL
used	NULL
to	NULL
investigate	NULL
a	NULL
possible	NULL
homo-aggregation	NULL
of	NULL
TRAMP	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
TRAMP	NULL
overexpression	NULL
leads	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
ligand	NULL
suggested	NULL
that	NULL
overexpression	NULL
of	NULL
TRAMP	NULL
most	NULL
likely	NULL
results	NULL
in	NULL
the	NULL
oligomerization	NULL
of	NULL
the	NULL
cytoplasmic	NULL
region	NULL
,	NULL
as	NULL
aggregation	NULL
of	NULL
the	NULL
death	NULL
domain	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
crucial	NULL
trigger	NULL
of	NULL
the	NULL
apoptotic	NULL
signal	NULL
pathway	NULL
(	NULL
Boldin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995a	NULL
;	NULL
Krammer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nagata	NULL
and	NULL
Golstein	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
two	NULL
expression	NULL
vectors	NULL
,	NULL
both	NULL
coding	NULL
for	NULL
the	NULL
identical	NULL
cytoplasmic	NULL
region	NULL
of	NULL
TRAMP	NULL
but	NULL
carrying	NULL
two	NULL
distinct	NULL
tag	NULL
epitopes	NULL
(	NULL
Myc	NULL
and	NULL
Flag	NULL
)	NULL
were	NULL
cotransfected	NULL
into	NULL
293T	NULL
cells	NULL
.	NULL

Figure	NULL
6B	NULL
shows	NULL
that	NULL
TRAMP	NULL
forms	NULL
homo-aggregates	NULL
,	NULL
whereas	NULL
interaction	NULL
with	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
Fas	NULL
was	NULL
not	NULL
detectable	NULL
.	NULL

TRAMP	NULL
Does	NULL
Not	NULL
Appear	NULL
to	NULL
Be	NULL
the	NULL
Receptor	NULL
of	NULL
TRAIL	NULL
,	NULL
TNFa	NULL
,	NULL
LTa1B2	NULL
,	NULL
or	NULL
FasL	NULL
To	NULL
determine	NULL
whether	NULL
TRAMP	NULL
is	NULL
the	NULL
receptor	NULL
of	NULL
one	NULL
of	NULL
the	NULL
known	NULL
ligands	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
,	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
TRAMP	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
Fc	NULL
portion	NULL
of	NULL
human	NULL
immunoglobulin	NULL
G1	NULL
(	NULL
IigG1	NULL
)	NULL
(	NULL
TRAMP-Fc	NULL
)	NULL
.	NULL

The	NULL
forced	NULL
di-merization	NULL
of	NULL
the	NULL
extracellular	NULL
region	NULL
of	NULL
TNFR-like	NULL
receptors	NULL
was	NULL
previously	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
a	NULL
considerable	NULL
increase	NULL
of	NULL
affinity	NULL
for	NULL
the	NULL
respective	NULL
ligands	NULL
such	NULL
that	NULL
ligand-receptor	NULL
interactions	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
members	NULL
can	NULL
be	NULL
studied	NULL
in	NULL
vitro	NULL
(	NULL
Byrn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
.	NULL

The	NULL
TRAMP-Fc	NULL
and	NULL
,	NULL
for	NULL
comparison	NULL
,	NULL
the	NULL
Fc	NULL
hybrids	NULL
of	NULL
human	NULL
and	NULL
mouse	NULL
Fas	NULL
(	NULL
mFas	NULL
and	NULL
hFas	NULL
)	NULL
(	NULL
Itoh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Watanabe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992b	NULL
)	NULL
,	NULL
mouse	NULL
lymphotoxin	NULL
B	NULL
receptor	NULL
(	NULL
mLTBR	NULL
)	NULL
(	NULL
Browning	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1996	NULL
)	NULL
,	NULL
and	NULL
human	NULL
TNFR1	NULL
(	NULL
ATNFR1	NULL
)	NULL
(	NULL
Loetscher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
were	NULL
coated	NULL
onto	NULL
wells	NULL
of	NULL
microtiter	NULL
plates	NULL
,	NULL
and	NULL
an	NULL
assortment	NULL
of	NULL
the	NULL
soluble	NULL
version	NULL
(	NULL
without	NULL
membrane	NULL
anchor	NULL
)	NULL
of	NULL
TNF	NULL
ligand	NULL
family	NULL
members	NULL
was	NULL
added	NULL
to	NULL
test	NULL
for	NULL
possible	NULL
binding	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
strong	NULL
interaction	NULL
was	NULL
found	NULL
between	NULL
hTNFa	NULL
and	NULL
mTNFR1-Fc	NULL
,	NULL
hFasL	NULL
and	NULL
human	NULL
or	NULL
mouse	NULL
Fas-Fc	NULL
,	NULL
and	NULL
hLTa1B2	NULL
and	NULL
mLTBR-Fc	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TRAMP-Fe	NULL
did	NULL
not	NULL
show	NULL
affinity	NULL
for	NULL
any	NULL
ligand	NULL
,	NULL
including	NULL
the	NULL
orphan	NULL
ligand	NULL
TRAIL	NULL
.	NULL

Since	NULL
anti-TRAMP	NULL
antibodies	NULL
recognized	NULL
the	NULL
TRAMP-Fc	NULL
hybrid	NULL
,	NULL
we	NULL
excluded	NULL
the	NULL
possibility	NULL
that	NULL
coating	NULL
of	NULL
the	NULL
wells	NULL
with	NULL
TRAMP-Fc	NULL
was	NULL
inefficient	NULL
and	NULL
responsible	NULL
for	NULL
the	NULL
inability	NULL
to	NULL
detect	NULL
a	NULL
binding	NULL
partner	NULL
.	NULL

This	NULL
set	NULL
of	NULL
experiments	NULL
also	NULL
revealed	NULL
that	NULL
TRAIL	NULL
had	NULL
no	NULL
detectable	NULL
affinity	NULL
for	NULL
any	NULL
of	NULL
the	NULL
other	NULL
receptor-Fc	NULL
constructs	NULL
tested	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
TRAMP	NULL
and	NULL
TRAIL	NULL
receptors	NULL
were	NULL
compared	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
.	NULL

In	NULL
melanoma	NULL
cell	NULL
lines	NULL
,	NULL
expression	NULL
of	NULL
both	NULL
TRAMP	NULL
and	NULL
TRAIL	NULL
receptors	NULL
was	NULL
comparably	NULL
high	NULL
,	NULL
while	NULL
no	NULL
correlation	NULL
was	NULL
found	NULL
in	NULL
Jurkat	NULL
T	NULL
lymphomas	NULL
(	NULL
and	NULL
various	NULL
other	NULL
TRAMP	NULL
,	NULL
an	NULL
Apoptosis-Signaling	NULL
Receptor	NULL
83	NULL
A	NULL
Flag-TRAMP	NULL
+	NULL
+	NULL
+	NULL
+	NULL
FADD	NULL
+	NULL
+	NULL
+	NULL
+	NULL
88	NULL
49	NULL
ms	NULL
--	NULL
ume	NULL
33	NULL
._	NULL
oe	NULL
e	NULL
Rw	NULL
<	NULL
c	NULL
39	NULL
.	NULL

Cell	NULL
Extract	NULL
IP	NULL
o-Flag-	NULL
TRAMP	NULL
B	NULL
Flag-TRAMP	NULL
+	NULL
+	NULL
+0	NULL
O+	NULL
+	NULL
+	NULL
Myc-TRAMP	NULL
_	NULL
+	NULL
+	NULL
Myc-Fas	NULL
+	NULL
+	NULL
88	NULL
-	NULL
l	NULL
’	NULL
49	NULL
-	NULL
E	NULL
M	NULL
.-	NULL
&	NULL
C	NULL
29	NULL
___	NULL
koe	NULL
19	NULL
_	NULL
<	NULL
:	NULL
Cell	NULL
Extract	NULL
IP	NULL
o-Flag-TRAMP	NULL
Figure	NULL
6	NULL
.	NULL

Homo-Oligomerization	NULL
of	NULL
the	NULL
Intracellular	NULL
Region	NULL
of	NULL
TRAMP	NULL
and	NULL
Its	NULL
Interaction	NULL
with	NULL
FADD	NULL
{	NULL
A	NULL
)	NULL
Interaction	NULL
of	NULL
TRAMP	NULL
with	NULL
FADD	NULL
.	NULL

293T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
Flag-tagged	NULL
TRAMP	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
and	NULL
FADD	NULL
(	NULL
2	NULL
g	NULL
)	NULL
,	NULL
and	NULL
the	NULL
FADD	NULL
expression	NULL
levels	NULL
were	NULL
assayed	NULL
in	NULL
cell	NULL
lysates	NULL
using	NULL
a	NULL
monoclonal	NULL
anti-FADD	NULL
antibody	NULL
.	NULL

The	NULL
cleared	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-Flag	NULL
antibodies	NULL
(	NULL
precipitating	NULL
TRAMP	NULL
)	NULL
,	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
coprecipitating	NULL
FADD	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-FADD	NULL
antibody	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Interaction	NULL
of	NULL
the	NULL
intracellular	NULL
regions	NULL
of	NULL
Flag-tagged	NULL
TRAMP	NULL
and	NULL
Myc-tagged	NULL
TRAMP	NULL
upon	NULL
overexpression	NULL
in	NULL
293T	NULL
cells	NULL
.	NULL

Levels	NULL
of	NULL
Myc-TRAMP	NULL
and	NULL
Myc-Fas	NULL
expression	NULL
in	NULL
cell	NULL
extracts	NULL
were	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
anti-Myc	NULL
antibody	NULL
(	NULL
left	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
of	NULL
cell	NULL
extracts	NULL
using	NULL
an	NULL
anti-Flag	NULL
antibody	NULL
(	NULL
precipitating	NULL
Flag-TRAMP	NULL
)	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
and	NULL
revealed	NULL
with	NULL
an	NULL
anti-Myc	NULL
antibody	NULL
to	NULL
detect	NULL
coprecipitating	NULL
Myc-TRAMP	NULL
or	NULL
Myc-Fas	NULL
,	NULL
respectively	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
TRAMP	NULL
oligomers	NULL
appeared	NULL
to	NULL
be	NULL
extremely	NULL
stable	NULL
,	NULL
since	NULL
they	NULL
were	NULL
partially	NULL
resistant	NULL
to	NULL
dissociation	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
boiling	NULL
SDS	NULL
(	NULL
see	NULL
bands	NULL
>	NULL
50	NULL
kDa	NULL
)	NULL
.	NULL

cell	NULL
lines	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
in	NULL
which	NULL
high	NULL
TRAIL	NULL
receptor	NULL
but	NULL
only	NULL
marginal	NULL
TRAMP	NULL
expression	NULL
was	NULL
detectable	NULL
(	NULL
Figure	NULL
7B	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
do	NULL
not	NULL
support	NULL
the	NULL
possibility	NULL
that	NULL
TRAMP	NULL
is	NULL
the	NULL
receptor	NULL
of	NULL
TRAIL	NULL
.	NULL

Chromosomal	NULL
Localization	NULL
of	NULL
TRAMP	NULL
The	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
TRAMP	NULL
gene	NULL
was	NULL
determined	NULL
by	NULL
fluorescence	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
FISH	NULL
)	NULL
analysis	NULL
(	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
condition	NULL
used	NULL
,	NULL
the	NULL
hybridization	NULL
efficiency	NULL
of	NULL
the	NULL
TRAMP	NULL
probe	NULL
was	NULL
approximately	NULL
91	NULL
%	NULL
(	NULL
among	NULL
100	NULL
mitotic	NULL
figures	NULL
checked	NULL
,	NULL
91	NULL
showed	NULL
signals	NULL
on	NULL
one	NULL
pair	NULL
of	NULL
the	NULL
chromosome	NULL
)	NULL
.	NULL

TRAMP	NULL
was	NULL
assigned	NULL
to	NULL
the	NULL
long	NULL
arm	NULL
of	NULL
human	NULL
chromosome	NULL
1	NULL
,	NULL
region	NULL
p36.2	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
TRAMP	NULL
gene	NULL
is	NULL
localized	NULL
to	NULL
a	NULL
region	NULL
where	NULL
other	NULL
receptors	NULL
(	NULL
CD30R	NULL
,	NULL
TNFR2	NULL
,	NULL
OXA40R	NULL
)	NULL
and	NULL
ligands	NULL
(	NULL
4-1BB	NULL
)	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
have	NULL
been	NULL
mapped	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
genes	NULL
are	NULL
clustered	NULL
.	NULL

Another	NULL
gene	NULL
cluster	NULL
of	NULL
TNF	NULL
family	NULL
members	NULL
is	NULL
found	NULL
on	NULL
chromosome	NULL
12	NULL
(	NULL
CD27R	NULL
,	NULL
12p13	NULL
;	NULL
LTBR	NULL
,	NULL
12p13	NULL
;	NULL
TNFR1	NULL
,	NULL
12p13.2	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
genes	NULL
coding	NULL
for	NULL
Fas	NULL
,	NULL
TNFR1	NULL
,	NULL
and	NULL
nerve	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
NGFR	NULL
)	NULL
are	NULL
distributed	NULL
on	NULL
various	NULL
other	NULL
chromosomes	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
Fas	NULL
,	NULL
10g24.1	NULL
;	NULL
CD40R	NULL
,	NULL
20q12	NULL
;	NULL
and	NULL
NGFR	NULL
,	NULL
17421	NULL
)	NULL
.	NULL

Discussion	NULL
We	NULL
have	NULL
characterized	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
,	NULL
designated	NULL
TRAMP	NULL
.	NULL

Like	NULL
most	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
,	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
TRAMP	NULL
contains	NULL
repeats	NULL
of	NULL
cysteine-rich	NULL
domains	NULL
that	NULL
are	NULL
known	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
its	NULL
cognate	NULL
ligand	NULL
.	NULL

TRAMP	NULL
is	NULL
the	NULL
fourth	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
(	NULL
TNFR1	NULL
,	NULL
Fas	NULL
,	NULL
NGFR	NULL
)	NULL
that	NULL
contains	NULL
a	NULL
death	NULL
domain	NULL
in	NULL
the	NULL
cytoplasmic	NULL
region	NULL
.	NULL

Its	NULL
percentage	NULL
amino	NULL
acid	NULL
identity	NULL
with	NULL
the	NULL
extracellular	NULL
cysteine-rich	NULL
domain	NULL
of	NULL
TNFR1	NULL
and	NULL
Fas	NULL
is	NULL
29	NULL
%	NULL
and	NULL
24	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
for	NULL
comparison	NULL
,	NULL
Fas	NULL
and	NULL
TNFR1	NULL
have	NULL
22	NULL
%	NULL
identical	NULL
amino	NULL
acids	NULL
)	NULL
.	NULL

In	NULL
the	NULL
death	NULL
domain	NULL
,	NULL
the	NULL
sequence	NULL
homology	NULL
between	NULL
TRAMP	NULL
and	NULL
TNFR1	NULL
is	NULL
highest	NULL
(	NULL
40	NULL
%	NULL
)	NULL
.	NULL

TRAMP	NULL
expression	NULL
is	NULL
found	NULL
predominantly	NULL
in	NULL
tissues	NULL
with	NULL
a	NULL
high	NULL
content	NULL
of	NULL
lymphocytes	NULL
.	NULL

Of	NULL
the	NULL
cells	NULL
and	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
TRAMP	NULL
was	NULL
abundantly	NULL
expressed	NULL
on	NULL
activated	NULL
lymphocytes	NULL
and	NULL
in	NULL
thymocytes	NULL
.	NULL

Thus	NULL
,	NULL
TRAMP	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
lymphocyte	NULL
cell	NULL
number	NULL
,	NULL
the	NULL
negative	NULL
selection	NULL
of	NULL
thymocytes	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Two	NULL
distinct	NULL
cDNAs	NULL
were	NULL
found	NULL
that	NULL
code	NULL
for	NULL
TRAMP	NULL
.	NULL

One	NULL
transcript	NULL
includes	NULL
a	NULL
stop	NULL
codon	NULL
after	NULL
the	NULL
third	NULL
of	NULL
six	NULL
cysteines	NULL
of	NULL
the	NULL
fourth	NULL
repeat	NULL
,	NULL
at	NULL
a	NULL
position	NULL
where	NULL
the	NULL
boundary	NULL
between	NULL
exons	NULL
5	NULL
and	NULL
6	NULL
is	NULL
located	NULL
in	NULL
the	NULL
TNFR1	NULL
gene	NULL
(	NULL
Fuchs	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Although	NULL
there	NULL
is	NULL
currently	NULL
no	NULL
evidence	NULL
for	NULL
the	NULL
existence	NULL
of	NULL
such	NULL
a	NULL
soluble	NULL
protein	NULL
,	NULL
it	NULL
would	NULL
be	NULL
predicted	NULL
to	NULL
act	NULL
as	NULL
a	NULL
secreted	NULL
inhibitor	NULL
of	NULL
TRAMP-TRAMP	NULL
ligand	NULL
interaction	NULL
.	NULL

Two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
,	NULL
both	NULL
of	NULL
poxvirus	NULL
origin	NULL
,	NULL
also	NULL
exist	NULL
as	NULL
soluble	NULL
receptors	NULL
.	NULL

T2	NULL
and	NULL
A53	NULL
function	NULL
to	NULL
complex	NULL
host-produced	NULL
TNF	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

T2	NULL
is	NULL
an	NULL
acquired	NULL
form	NULL
of	NULL
TNFR2	NULL
,	NULL
while	NULL
A53	NULL
shows	NULL
much	NULL
lower	NULL
sequence	NULL
homology	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
third	NULL
TNF	NULL
receptor	NULL
.	NULL

The	NULL
fatal	NULL
virulence	NULL
of	NULL
wild-type	NULL
myxoma	NULL
poxvirus	NULL
is	NULL
reduced	NULL
by	NULL
nearly	NULL
50	NULL
%	NULL
in	NULL
viral	NULL
mutants	NULL
only	NULL
differing	NULL
by	NULL
an	NULL
inactivated	NULL
T2	NULL
gene	NULL
(	NULL
Upton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

It	NULL
will	NULL
therefore	NULL
be	NULL
interesting	NULL
to	NULL
identify	NULL
and	NULL
characterize	NULL
the	NULL
soluble	NULL
TRAMP	NULL
form	NULL
.	NULL

Interestingly	NULL
,	NULL
a	NULL
short	NULL
transcript	NULL
that	NULL
possibly	NULL
corresponds	NULL
to	NULL
the	NULL
soluble	NULL
receptor	NULL
TRAMP	NULL
is	NULL
highly	NULL
up-regulated	NULL
in	NULL
mice	NULL
that	NULL
lack	NULL
a	NULL
functional	NULL
Fas	NULL
.	NULL

The	NULL
cytoplasmic	NULL
region	NULL
of	NULL
TRAMP	NULL
contains	NULL
a	NULL
death	NULL
domain	NULL
,	NULL
which	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
signal	NULL
cell	NULL
death	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Natural	NULL
or	NULL
artificial	NULL
mutations	NULL
in	NULL
this	NULL
region	NULL
disrupt	NULL
the	NULL
ability	NULL
of	NULL
Fas	NULL
and	NULL
TNFR1	NULL
to	NULL
initiate	NULL
these	NULL
signals	NULL
(	NULL
Nagata	NULL
,	NULL
1994	NULL
;	NULL
Tartaglia	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

It	NULL
was	NULL
therefore	NULL
not	NULL
surprising	NULL
that	NULL
overexpression	NULL
of	NULL
TRAMP	NULL
both	NULL
potently	NULL
induced	NULL
proinflammatory	NULL
activity	NULL
and	NULL
cell	NULL
death	NULL
.	NULL

Overexpression	NULL
of	NULL
TNFR1	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
trigger	NULL
NF-kB	NULL
activation	NULL
in	NULL
a	NULL
ligand-independent	NULL
manner	NULL
(	NULL
Smith	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6	NULL
,	NULL
overexpression	NULL
of	NULL
TRAMP	NULL
resulted	NULL
Immunity	NULL
B4	NULL
s	NULL
hsFasL	NULL
a	NULL
hsTrail	NULL
>	NULL
hsLTo1B2	NULL
o	NULL
2	NULL
2	NULL
9	NULL
T	NULL
1	NULL
o	NULL
0	NULL
1	NULL
1	NULL
0	NULL
0	NULL
0	NULL
faf	NULL
£8	NULL
g	NULL
-	NULL
Pat	NULL
$	NULL
2p	NULL
/	NULL
$	NULL
8	NULL
$	NULL
8	NULL
e	NULL
/	NULL
#	NULL
ow	NULL
A	NULL
'	NULL
¥	NULL
4	NULL
o	NULL
Z	NULL
a	NULL
flit/amy—	NULL
Ef	NULL
F	NULL
E	NULL
&	NULL
$	NULL
f	NULL
5	NULL
F	NULL
&	NULL
Saf	NULL
sf	NULL
&	NULL
E	NULL
2	NULL
Z	NULL
$	NULL
E	NULL
<	NULL
L	NULL
z	NULL
<	NULL
€€	NULL
43	NULL
€	NULL
Ek	NULL
E	NULL
26	NULL
f	NULL
hat	NULL
EC	NULL
E	NULL
c	NULL
18	NULL
hsTNFo	NULL
.	NULL

a	NULL
Control	NULL
o-TRAMP	NULL
0.4	NULL
1	NULL
2	NULL
o	NULL
$	NULL
80-5	NULL
R	NULL
0.2	NULL
0	NULL
0	NULL
0	NULL
$	NULL
e	NULL
$	NULL
e	NULL
go	NULL
gg	NULL
22	NULL
e	NULL
do	NULL
g	NULL
ge	NULL
C	NULL
#	NULL
U	NULL
(	NULL
Z	NULL
A	NULL
'	NULL
8	NULL
¥	NULL
E	NULL
oz	NULL
a	NULL
#	NULL
a	NULL
cf	NULL
cf	NULL
&	NULL
EoS	NULL
gE	NULL
s	NULL
£	NULL
E	NULL
5	NULL
E	NULL
s	NULL
E5	NULL
Lz	NULL
<	NULL
55425	NULL
8542§	NULL
g	NULL
£	NULL
Ec	NULL
[	NULL
C	NULL
E2	NULL
iE	NULL
z	NULL
E	NULL
C	NULL
E	NULL
Z	NULL
B	NULL
ME26O	NULL
$	NULL
a	NULL
E	NULL
C	NULL
c	NULL
O	NULL
10°	NULL
1	NULL
10°	NULL
10°	NULL
105	NULL
10°	NULL
hi	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10°	NULL
=-	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10°	NULL
JURKAT	NULL
.	NULL

E	NULL
3	NULL
2	NULL
©	NULL
C	NULL
10°	NULL
10	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
1d	NULL
10°	NULL
10°	NULL
10°	NULL
10°	NULL
10	NULL
10°	NULL
10°	NULL
10°	NULL
-T	NULL
RAMP	NULL
Flag-TRAIL	NULL
Flag-TNFa	NULL
Flag-FasL	NULL
Figure	NULL
7	NULL
.	NULL

TRAMP	NULL
Does	NULL
Not	NULL
Appear	NULL
to	NULL
Be	NULL
the	NULL
Receptor	NULL
of	NULL
Known	NULL
Apoptosis-Inducing	NULL
Ligands	NULL
of	NULL
the	NULL
TNF	NULL
Family	NULL
(	NULL
A	NULL
)	NULL
Interaction	NULL
of	NULL
TNF	NULL
ligand	NULL
and	NULL
receptor	NULL
family	NULL
members	NULL
.	NULL

Wells	NULL
of	NULL
microtiter	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
fusion	NULL
proteins	NULL
of	NULL
the	NULL
indicated	NULL
TNF	NULL
receptor	NULL
family	NULL
members	NULL
with	NULL
human	NULL
immunoglobulin	NULL
Fo	NULL
(	NULL
rec-Fc	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
tagged	NULL
ligands	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
anti-tag	NULL
antibodies	NULL
(	NULL
anti-Flag	NULL
for	NULL
for	NULL
FasL	NULL
,	NULL
TRAIL	NULL
,	NULL
and	NULL
TNFa	NULL
;	NULL
anti-Myc	NULL
for	NULL
LTa1B2	NULL
)	NULL
.	NULL

Efficient	NULL
coating	NULL
with	NULL
TRAMP-Fc	NULL
was	NULL
verified	NULL
using	NULL
a	NULL
polyclonal	NULL
anti-	NULL
TRAMP	NULL
antibody	NULL
.	NULL

In	NULL
the	NULL
control	NULL
panel	NULL
,	NULL
no	NULL
ligand	NULL
was	NULL
included	NULL
in	NULL
the	NULL
assay	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Comparison	NULL
of	NULL
TRAMP	NULL
and	NULL
TRAIL	NULL
receptor	NULL
surface	NULL
expression	NULL
.	NULL

The	NULL
distribution	NULL
of	NULL
TRAIL	NULL
receptor	NULL
and	NULL
TRAMP	NULL
(	NULL
and	NULL
for	NULL
comparison	NULL
Fas	NULL
and	NULL
TNFRs	NULL
)	NULL
were	NULL
compared	NULL
in	NULL
Me260	NULL
(	NULL
Melanoma	NULL
)	NULL
and	NULL
Jurkat	NULL
(	NULL
T	NULL
cell	NULL
lymphoma	NULL
)	NULL
cell	NULL
lines	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
Fas	NULL
,	NULL
TNFRs	NULL
,	NULL
and	NULL
TRAIL	NULL
receptor	NULL
was	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
tagged	NULL
FasL	NULL
,	NULL
TNFa	NULL
,	NULL
and	NULL
TRAIL	NULL
,	NULL
respectively	NULL
.	NULL

TRAMP	NULL
expression	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
polyclonal	NULL
antibody	NULL
AL104	NULL
.	NULL

in	NULL
aggregation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
region	NULL
,	NULL
therefore	NULL
allowing	NULL
direct	NULL
complex	NULL
formation	NULL
with	NULL
downstream	NULL
signaling	NULL
partners	NULL
.	NULL

Akin	NULL
to	NULL
TRADD-induced	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Hsu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
reporter	NULL
gene	NULL
was	NULL
best	NULL
demonstrated	NULL
when	NULL
the	NULL
cell	NULL
death	NULL
pathway	NULL
was	NULL
inhibited	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
cell	NULL
death	NULL
pathway	NULL
and	NULL
the	NULL
one	NULL
leading	NULL
to	NULL
the	NULL
proinflammatory	NULL
response	NULL
are	NULL
distinct	NULL
.	NULL

Whether	NULL
TRAMP-induced	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
mediated	NULL
by	NULL
TRADD	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

TRAMP	NULL
is	NULL
also	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Similar	NULL
to	NULL
Fas	NULL
,	NULL
TRAMP	NULL
is	NULL
able	NULL
to	NULL
recruit	NULL
FADD	NULL
upon	NULL
overexpres-sion	NULL
,	NULL
and	NULL
it	NULL
is	NULL
reasonable	NULL
to	NULL
infer	NULL
that	NULL
TRAMP-com-plexed	NULL
FADD	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
FLICE	NULL
or	NULL
the	NULL
FLICE	NULL
homolog	NULL
Mch4	NULL
(	NULL
Fernandesalnemri	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

TRAMP	NULL
-triggered	NULL
cell	NULL
death	NULL
is	NULL
blocked	NULL
by	NULL
zVAD-fmk	NULL
,	NULL
which	NULL
is	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
ICE-like	NULL
proteases	NULL
,	NULL
including	NULL
FLICE	NULL
(	NULL
M.	NULL
T.	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Bcl-2	NULL
,	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
other	NULL
forms	NULL
of	NULL
signals	NULL
causing	NULL
apoptosis	NULL
(	NULL
UV	NULL
,	NULL
growth	NULL
factor	NULL
withdrawal	NULL
,	NULL
etc	NULL
.	NULL
)	NULL

(	NULL
Hawkins	NULL
and	NULL
Vaux	NULL
,	NULL
1994	NULL
;	NULL
Korsmeyer	NULL
,	NULL
1995	NULL
)	NULL
was	NULL
ineffective	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
its	NULL
variable	NULL
inhibitory	NULL
activity	NULL
on	NULL
the	NULL
Fas	NULL
pathway	NULL
(	NULL
Schroter	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Strasser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
possible	NULL
interaction	NULL
of	NULL
TNF	NULL
family	NULL
members	NULL
known	NULL
to	NULL
induce	NULL
cell	NULL
death	NULL
with	NULL
TRAMP	NULL
was	NULL
assayed	NULL
using	NULL
a	NULL
sensitive	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
,	NULL
based	NULL
assay	NULL
.	NULL

While	NULL
strong	NULL
signals	NULL
were	NULL
obtained	NULL
with	NULL
TRAMP	NULL
,	NULL
an	NULL
Apoptosis-Signaling	NULL
Receptor	NULL
85	NULL
Chromosome	NULL
1	NULL
known	NULL
ligands	NULL
,	NULL
no	NULL
signal	NULL
above	NULL
background	NULL
was	NULL
measured	NULL
with	NULL
TRAMP	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
TRAIL	NULL
,	NULL
can	NULL
not	NULL
bind	NULL
TRAMP	NULL
.	NULL

These	NULL
results	NULL
were	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
TRAIL	NULL
receptor	NULL
and	NULL
TRAMP	NULL
expression	NULL
differed	NULL
in	NULL
various	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

However	NULL
,	NULL
this	NULL
conclusion	NULL
has	NULL
to	NULL
be	NULL
taken	NULL
with	NULL
caution	NULL
.	NULL

The	NULL
most	NULL
conserved	NULL
region	NULL
,	NULL
the	NULL
cytoplasmic	NULL
death	NULL
domain	NULL
,	NULL
is	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
corresponding	NULL
region	NULL
of	NULL
TNFR1	NULL
,	NULL
and	NULL
therefore	NULL
the	NULL
existence	NULL
of	NULL
heterotrimeric	NULL
receptors	NULL
,	NULL
consisting	NULL
of	NULL
,	NULL
for	NULL
example	NULL
,	NULL
TNFR1	NULL
;	NULL
TRAMP	NULL
;	NULL
,	NULL
can	NULL
not	NULL
be	NULL
excluded	NULL
.	NULL

LTo1B2	NULL
may	NULL
be	NULL
considered	NULL
the	NULL
prototype	NULL
of	NULL
such	NULL
a	NULL
hetero-oligo-mer	NULL
in	NULL
the	NULL
TNF	NULL
ligand	NULL
family	NULL
.	NULL

If	NULL
such	NULL
a	NULL
mixed	NULL
receptor	NULL
association	NULL
exists	NULL
in	NULL
vivo	NULL
,	NULL
the	NULL
assay	NULL
system	NULL
used	NULL
here	NULL
would	NULL
have	NULL
failed	NULL
to	NULL
detect	NULL
it	NULL
.	NULL

Still	NULL
,	NULL
the	NULL
most	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
the	NULL
ligand	NULL
of	NULL
TRAMP	NULL
is	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
ligand	NULL
family	NULL
,	NULL
which	NULL
,	NULL
when	NULL
identified	NULL
,	NULL
may	NULL
provide	NULL
new	NULL
insights	NULL
into	NULL
the	NULL
pleiotropic	NULL
biological	NULL
activities	NULL
of	NULL
this	NULL
family	NULL
of	NULL
ligands	NULL
and	NULL
receptors	NULL
.	NULL

Experimental	NULL
Procedures	NULL
Reagents	NULL
and	NULL
Cell	NULL
Lines	NULL
The	NULL
293T	NULL
human	NULL
embryo	NULL
kidney	NULL
(	NULL
HEK	NULL
)	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
Marcus	NULL
Peter	NULL
(	NULL
Heidelberg	NULL
)	NULL
and	NULL
melanoma	NULL
cell	NULL
lines	NULL
used	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Hahne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
(	NULL
PBLs	NULL
)	NULL
from	NULL
a	NULL
buffy	NULL
coat	NULL
preparation	NULL
were	NULL
purified	NULL
over	NULL
Ficoll	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
activated	NULL
with	NULL
1	NULL
pg/ml	NULL
PHA	NULL
and	NULL
interleukin-2	NULL
{	NULL
150	NULL
U/m	NULL
!	NULL
)	NULL

.	NULL

LAN-1	NULL
and	NULL
LN215	NULL
cells	NULL
were	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
Nicole	NULL
Gross	NULL
and	NULL
Dr.	NULL
E.	NULL
van	NULL
Meir	NULL
,	NULL
respectively	NULL
.	NULL

Other	NULL
cell	NULL
lines	NULL
referred	NULL
to	NULL
in	NULL
this	NULL
paper	NULL
have	NULL
been	NULL
deposited	NULL
in	NULL
and	NULL
described	NULL
by	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

A	NULL
Flag-tagged	NULL
version	NULL
of	NULL
the	NULL
extracellular	NULL
domain	NULL
(	NULL
residues	NULL
103-281	NULL
)	NULL
of	NULL
human	NULL
FasL	NULL
was	NULL
produced	NULL
in	NULL
293	NULL
HEK	NULL
cells	NULL
(	NULL
P.	NULL
S.	NULL
,	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Flag-tagged	NULL
recombinant	NULL
soluble	NULL
human	NULL
TRAIL	NULL
(	NULL
residues	NULL
Thr-95-Gly-281	NULL
)	NULL
and	NULL
Flag-tagged	NULL
human	NULL
TNFa	NULL
{	NULL
residues	NULL
Ser-85-	NULL
FISH	NULL
DAPI	NULL
Figure	NULL
8	NULL
.	NULL

Chromosomal	NULL
Localization	NULL
of	NULL
the	NULL
TRAMP	NULL
Gene	NULL
Diagram	NULL
of	NULL
FISH	NULL
mapping	NULL
results	NULL
for	NULL
the	NULL
TRAMP	NULL
probe	NULL
.	NULL

Each	NULL
dot	NULL
represents	NULL
the	NULL
double	NULL
FISH	NULL
signals	NULL
detected	NULL
on	NULL
human	NULL
chromosome	NULL
1p36.2	NULL
.	NULL

The	NULL
left	NULL
panel	NULL
shows	NULL
an	NULL
example	NULL
of	NULL
FISH	NULL
mapping	NULL
(	NULL
arrowhead	NULL
)	NULL
;	NULL
the	NULL
right	NULL
panel	NULL
corresponds	NULL
to	NULL
the	NULL
same	NULL
mitotic	NULL
figure	NULL
stained	NULL
with	NULL
DAPI	NULL
.	NULL

Leu-233	NULL
)	NULL
were	NULL
produced	NULL
in	NULL
bacteria	NULL
(	NULL
P.	NULL
S.	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Myc-tagged	NULL
LTa1B2	NULL
was	NULL
made	NULL
in	NULL
insect	NULL
cells	NULL
using	NULL
the	NULL
baculovirus	NULL
system	NULL
(	NULL
Browning	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
mouse	NULL
Fas-Fc	NULL
were	NULL
purified	NULL
from	NULL
supernatants	NULL
of	NULL
stably	NULL
transfected	NULL
293	NULL
HEK	NULL
cell	NULL
lines	NULL
;	NULL
human	NULL
TRAMP-Fc	NULL
was	NULL
from	NULL
transiently	NULL
transfected	NULL
2937	NULL
cell	NULL
lines	NULL
.	NULL

Human	NULL
TNFR1-Fc	NULL
and	NULL
human	NULL
LTBR-Fc	NULL
were	NULL
made	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Crowe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
FADD	NULL
expression	NULL
plasmid	NULL
(	NULL
pcDNA3	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
Dr.	NULL
Martinou	NULL
(	NULL
Glaxo	NULL
,	NULL
Geneva	NULL
)	NULL
.	NULL

The	NULL
extracellular	NULL
domain	NULL
of	NULL
TRAMP	NULL
,	NULL
encompassing	NULL
residues	NULL
1-175	NULL
,	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
proofreading	NULL
DNA	NULL
polymer-ase	NULL
Pwo	NULL
(	NULL
Boehringer	NULL
)	NULL
using	NULL
a	NULL
specific	NULL
5	NULL
'	NULL
forward	NULL
primer	NULL
flanked	NULL
by	NULL
a	NULL
BamHI	NULL
site	NULL
(	NULL
5'-TCCGGATCCCAGGGCGGCACTCGT-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
3	NULL
'	NULL
reverse	NULL
primer	NULL
flanked	NULL
by	NULL
a	NULL
Sall	NULL
site	NULL
(	NULL
5'-GTCGACCTGCCTCCAGCC	NULL
ACAG-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
pCRII	NULL
vector	NULL
(	NULL
Invitrogen	NULL
)	NULL
and	NULL
then	NULL
subcloned	NULL
in	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
pCMV	NULL
promoter	NULL
(	NULL
PCRIII	NULL
;	NULL
Invitrogen	NULL
)	NULL
as	NULL
a	NULL
BamHI-Sall	NULL
insert	NULL
in-frame	NULL
behind	NULL
the	NULL
signal	NULL
sequence	NULL
of	NULL
the	NULL
heavy	NULL
chain	NULL
of	NULL
the	NULL
immunoglobulin	NULL
{	NULL
Ig	NULL
)	NULL
and	NULL
in	NULL
front	NULL
of	NULL
a	NULL
Sall-Not	NULL
!	NULL

fragment	NULL
containing	NULL
the	NULL
cDNA	NULL
of	NULL
the	NULL
hinge	NULL
,	NULL
C	NULL
,	NULL
,3	NULL
and	NULL
C	NULL
,	NULL
,4	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
IgG1	NULL
(	NULL
Fc	NULL
domain	NULL
}	NULL
.	NULL

This	NULL
strategy	NULL
resulted	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
a	NULL
full-length	NULL
,	NULL
highly	NULL
expressed	NULL
secreted	NULL
TRAMP-Fc	NULL
molecule	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
(	NULL
MAbs	NULL
)	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
Western	NULL
blotting	NULL
include	NULL
the	NULL
following	NULL
:	NULL
an	NULL
anti-Flag	NULL
antibody	NULL
and	NULL
anti-Flag	NULL
agarose	NULL
(	NULL
Kodak	NULL
International	NULL
Biotechnologies	NULL
)	NULL
,	NULL
an	NULL
anti-FADD	NULL
antibody	NULL
directed	NULL
against	NULL
amino	NULL
acids	NULL
94-208	NULL
of	NULL
human	NULL
FADD	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
)	NULL
,	NULL
and	NULL
an	NULL
antibody	NULL
against	NULL
the	NULL
Myc	NULL
epi-tope	NULL
(	NULL
9E10	NULL
;	NULL
provided	NULL
by	NULL
R.	NULL
Iggo	NULL
,	NULL
ISREC	NULL
)	NULL
.	NULL

Antiserum	NULL
against	NULL
TRAMP	NULL
was	NULL
generated	NULL
against	NULL
a	NULL
peptide	NULL
spanning	NULL
amino	NULL
acids	NULL
1-23	NULL
of	NULL
the	NULL
mature	NULL
TRAMP	NULL
(	NULL
QGGTRSPRCDCAGDFHKKIGLFC	NULL
)	NULL
synthesized	NULL
using	NULL
the	NULL
multiple	NULL
antigen	NULL
technology	NULL
(	NULL
Francis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
antiserum	NULL
(	NULL
AL104	NULL
)	NULL
was	NULL
affinity	NULL
purified	NULL
on	NULL
the	NULL
TRAMP	NULL
peptide	NULL
coupled	NULL
to	NULL
CNBr-Sepharose	NULL
4B	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
TRAMP	NULL
cDNA	NULL
Several	NULL
EST	NULL
clones	NULL
that	NULL
potentially	NULL
encoded	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
were	NULL
identified	NULL
in	NULL
the	NULL
dbEST	NULL
database	NULL
at	NULL
the	NULL
National	NULL
Center	NULL
for	NULL
Biotechnology	NULL
Information	NULL
by	NULL
performing	NULL
a	NULL
database	NULL
search	NULL
using	NULL
generalized	NULL
profile	NULL
method	NULL
(	NULL
Bucher	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
based	NULL
on	NULL
the	NULL
sequence	NULL
homology	NULL
among	NULL
TNF	NULL
receptor	NULL
family	NULL
members	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
clones	NULL
(	NULL
insert	NULL
size	NULL
0.6-0.8	NULL
kb	NULL
)	NULL
were	NULL
derived	NULL
from	NULL
an	NULL
adult	NULL
brain	NULL
cDNA	NULL
library	NULL
(	NULL
GenBank	NULL
accession	NULL
numbers	NULL
H46378	NULL
,	NULL
Immunity	NULL
86	NULL
H41851	NULL
,	NULL
H49675	NULL
,	NULL
and	NULL
H41522	NULL
)	NULL
;	NULL
the	NULL
longest	NULL
clone	NULL
(	NULL
1.7	NULL
kb	NULL
;	NULL
GenBank	NULL
accession	NULL
number	NULL
N71141	NULL
)	NULL
was	NULL
from	NULL
a	NULL
fetal	NULL
lung	NULL
cDNA	NULL
library	NULL
.	NULL

The	NULL
inserts	NULL
were	NULL
sequenced	NULL
by	NULL
conventional	NULL
methods	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
sequences	NULL
were	NULL
aligned	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis	NULL
Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
human	NULL
multiple	NULL
tissue	NULL
Northen	NULL
blots	NULL
|	NULL
and	NULL
II	NULL
(	NULL
Clontech	NULL
7760-1	NULL
and	NULL
7759-1	NULL
)	NULL
or	NULL
by	NULL
resolution	NULL
of	NULL
total	NULL
RNA	NULL
from	NULL
mouse	NULL
cells	NULL
(	NULL
Wilson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
on	NULL
1.4	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
18	NULL
%	NULL
formaldehyde	NULL
and	NULL
blotting	NULL
onto	NULL
Hybond-N	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
preincu-bated	NULL
in	NULL
hybridization	NULL
solution	NULL
(	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
2.5	NULL
%	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
10	NULL
mM	NULL
EDTA	NULL
,	NULL
2x	NULL
SSC	NULL
[	NULL
pH	NULL
7.0	NULL
]	NULL
,	NULL
50	NULL
mM	NULL
NaH	NULL
,	NULL
PO	NULL
,	NULL
[	NULL
pH	NULL
6.5	NULL
]	NULL
,	NULL
200	NULL
pg/ml	NULL
boiled	NULL
and	NULL
sonicated	NULL
herring	NULL
sperm	NULL
DNA	NULL
)	NULL
for	NULL
at	NULL
least	NULL
4	NULL
hr	NULL
at	NULL
hybridization	NULL
temperature	NULL
(	NULL
60°C	NULL
)	NULL
.	NULL

The	NULL
heat-denatured	NULL
antisense	NULL
RNA	NULL
probe	NULL
was	NULL
added	NULL
at	NULL
1.5	NULL
x	NULL
10°	NULL
cpm	NULL
per	NULL
milliliter	NULL
in	NULL
fresh	NULL
hybridization	NULL
solution	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
incubated	NULL
12-24	NULL
hr	NULL
at	NULL
65°C	NULL
and	NULL
washed	NULL
at	NULL
least	NULL
three	NULL
times	NULL
with	NULL
increasing	NULL
stringency	NULL
and	NULL
exposed	NULL
at	NULL
-70°C	NULL
.	NULL

Construction	NULL
of	NULL
TRAMP	NULL
Expression	NULL
Vectors	NULL
The	NULL
full-length	NULL
TRAMP	NULL
was	NULL
amplified	NULL
using	NULL
the	NULL
Pwo	NULL
DNA	NULL
polymer-ase	NULL
using	NULL
a	NULL
specific	NULL
5	NULL
'	NULL
forward	NULL
primer	NULL
flanked	NULL
by	NULL
a	NULL
BamHI	NULL
site	NULL
(	NULL
5'-TCCGGATCCCAGGGCGGCACTCGT-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
specific	NULL
3	NULL
'	NULL
reverse	NULL
primer	NULL
flanked	NULL
by	NULL
an	NULL
Xbal	NULL
site	NULL
(	NULL
5'-GACTCTAGACGCCTAGGT	NULL
GGCAAGT-3	NULL
'	NULL
)	NULL
.	NULL

The	NULL
amplified	NULL
fragment	NULL
was	NULL
cut	NULL
with	NULL
BamH	NULL
!	NULL

|-Xbal	NULL
and	NULL
cloned	NULL
into	NULL
a	NULL
modified	NULL
version	NULL
of	NULL
pCRIII	NULL
(	NULL
Invitrogen	NULL
)	NULL
in-frame	NULL
with	NULL
the	NULL
signal	NULL
peptide	NULL
of	NULL
the	NULL
heavy	NULL
chain	NULL
of	NULL
IgG	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
TRAMP	NULL
{	NULL
amino	NULL
acids	NULL
197-393	NULL
)	NULL
was	NULL
PCR	NULL
amplified	NULL
using	NULL
the	NULL
two	NULL
primers	NULL
5'-GAATTCACCTACACATACCGC-3	NULL
'	NULL
and	NULL
5'-CTCGAGTCACGGGCCGCGCTG-3	NULL
'	NULL
containing	NULL
an	NULL
EcoRl	NULL
and	NULL
Xhol	NULL
site	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
a	NULL
modified	NULL
pCRIII	NULL
vector	NULL
in-frame	NULL
with	NULL
an	NULL
N-terminal	NULL
Flag	NULL
epitope	NULL
.	NULL

Cell	NULL
Lysis	NULL
,	NULL
Coimmunoprecipitation	NULL
,	NULL
and	NULL
Western	NULL
Blot	NULL
Analysis	NULL
For	NULL
analysis	NULL
of	NULL
various	NULL
cell	NULL
lines	NULL
for	NULL
TRAMP	NULL
expression	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
submitted	NULL
twice	NULL
to	NULL
Triton	NULL
X-114	NULL
extraction	NULL
(	NULL
Bordier	NULL
,	NULL
1981	NULL
)	NULL
.	NULL

The	NULL
detergent	NULL
phases	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
precipitated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
MeOH/CHCI	NULL
;	NULL
(	NULL
1:4	NULL
[	NULL
v/v	NULL
]	NULL
)	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
BCA	NULL
protein	NULL
determination	NULL
kit	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Membrane	NULL
proteins	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
diluted	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
and	NULL
analyzed	NULL
for	NULL
TRAMP	NULL
expression	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
Western	NULL
blotting	NULL
.	NULL

For	NULL
coimmunoprecipitation	NULL
experiments	NULL
,	NULL
2937	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
procedure	NULL
(	NULL
Sambrook	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
for	NULL
8	NULL
hr	NULL
.	NULL

At	NULL
26	NULL
hr	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
from	NULL
a	NULL
10	NULL
mm	NULL
plate	NULL
were	NULL
lysed	NULL
in	NULL
200	NULL
l	NULL
of	NULL
lysis	NULL
buffer	NULL
{	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCI	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
)	NULL
)	NULL
supplemented	NULL
with	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
pefabloc-sc	NULL
(	NULL
Serva	NULL
)	NULL
,	NULL
and	NULL
10	NULL
g/ml	NULL
of	NULL
each	NULL
leupeptin	NULL
and	NULL
aprotinin	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Postnuclear	NULL
lysates	NULL
were	NULL
precleared	NULL
for	NULL
at	NULL
least	NULL
1	NULL
hr	NULL
on	NULL
Sepharose	NULL
6B	NULL
(	NULL
Pharmacia	NULL
)	NULL
before	NULL
precipitation	NULL
for	NULL
2	NULL
hr	NULL
or	NULL
overnight	NULL
with	NULL
3	NULL
pl	NULL
of	NULL
anti-Flag	NULL
agarose	NULL
or	NULL
1	NULL
pg	NULL
of	NULL
anti-Myc	NULL
(	NULL
E10	NULL
)	NULL
previously	NULL
bound	NULL
to	NULL
protein	NULL
G-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Precipitates	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
lysis	NULL
buffer	NULL
containing	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
boiled	NULL
in	NULL
sample	NULL
buffer	NULL
,	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
(	NULL
Hybond	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
extracts	NULL
and	NULL
immunoprecipitates	NULL
,	NULL
blots	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
skim	NULL
milk	NULL
,	NULL
0.5	NULL
%	NULL
Tween	NULL
20	NULL
in	NULL
PBS	NULL
and	NULL
revealed	NULL
using	NULL
affinity-purified	NULL
anti-T	NULL
RAMP	NULL
antibody	NULL
AL104	NULL
at	NULL
1:2000	NULL
dilution	NULL
,	NULL
anti-Flag	NULL
MAb	NULL
at	NULL
5	NULL
g/ml	NULL
,	NULL
anti-FADD	NULL
MAb	NULL
at	NULL
1	NULL
g/ml	NULL
,	NULL
and	NULL
anti-Myc	NULL
MAb	NULL
(	NULL
9E10	NULL
)	NULL
at	NULL
5	NULL
g/ml	NULL
,	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
per-oxidase-conjugated	NULL
secondary	NULL
antibody	NULL
(	NULL
Jackson	NULL
Laboratories	NULL
)	NULL
.	NULL

Bound	NULL
antibody	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
enhanced	NULL
chemilumines-cence	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
according	NULL
to	NULL
the	NULL
instructions	NULL
of	NULL
the	NULL
manufac-turer	NULL
.	NULL

Immunofluorescence	NULL
293T	NULL
cells	NULL
plated	NULL
onto	NULL
coverslips	NULL
at	NULL
a	NULL
density	NULL
of	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
in	NULL
a	NULL
35	NULL
mm	NULL
dish	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
full-length	NULL
TRAMP	NULL
con-struct	NULL
.	NULL

At	NULL
20	NULL
hr	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
coverslips	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
formaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
10	NULL
min	NULL
incubation	NULL
in	NULL
95	NULL
%	NULL
EtOH	NULL
,	NULL
5	NULL
%	NULL
acetic	NULL
acid	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
with	NULL
affinity-purified	NULL
anti-	NULL
TRAMP	NULL
AL104	NULL
antibody	NULL
at	NULL
25	NULL
ug/ml	NULL
,	NULL
followed	NULL
by	NULL
anti-rabbit	NULL
immunoglobu-lin-FITC	NULL
{	NULL
Dianova	NULL
,	NULL
Hamburg	NULL
,	NULL
Federal	NULL
Republic	NULL
of	NULL
Germany	NULL
)	NULL
diluted	NULL
1:150	NULL
and	NULL
examined	NULL
by	NULL
confocal	NULL
microscopy	NULL
(	NULL
Zeiss	NULL
)	NULL
.	NULL

FACS	NULL
Staining	NULL
Cells	NULL
were	NULL
stained	NULL
with	NULL
affinity-purified	NULL
anti-T	NULL
RAMP	NULL
AL104	NULL
antibody	NULL
at	NULL
a	NULL
1:20	NULL
dilution	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
washed	NULL
with	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
FACS	NULL
)	NULL
buffer	NULL
(	NULL
PBS	NULL
,	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
0.02	NULL
%	NULL
NaN	NULL
;	NULL
)	NULL
,	NULL
pelleted	NULL
at	NULL
200	NULL
x	NULL
g	NULL
,	NULL
and	NULL
stained	NULL
with	NULL
anti-rabbit-FITC	NULL
(	NULL
Silenus	NULL
Labo-ratory	NULL
,	NULL
Australia	NULL
)	NULL
,	NULL
diluted	NULL
1:400	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
analyzed	NULL
in	NULL
the	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

TRAIL	NULL
receptor	NULL
,	NULL
Fas	NULL
,	NULL
and	NULL
TNFR	NULL
expression	NULL
on	NULL
cell	NULL
lines	NULL
was	NULL
analyzed	NULL
by	NULL
FACS	NULL
using	NULL
the	NULL
respective	NULL
Flag-tagged	NULL
ligands	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
as	NULL
detecting	NULL
probes	NULL
.	NULL

Bound	NULL
ligands	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
anti-Flag	NULL
M2	NULL
antibody	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
FITC-labeled	NULL
anti-mouse	NULL
antibody	NULL
(	NULL
Di-anova	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
Reporter	NULL
Assay	NULL
Approximately	NULL
2	NULL
x	NULL
10°	NULL
293T	NULL
cells	NULL
were	NULL
seeded	NULL
on	NULL
35	NULL
mm	NULL
dishes	NULL
and	NULL
grown	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
at	NULL
37°C	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
the	NULL
next	NULL
day	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
.	NULL

The	NULL
precipitate	NULL
was	NULL
removed	NULL
after	NULL
8	NULL
hr	NULL
,	NULL
and	NULL
the	NULL
ICE	NULL
family	NULL
inhibitor	NULL
zZVAD-fmk	NULL
(	NULL
50	NULL
wM	NULL
;	NULL
Enzyme	NULL
Systems	NULL
Products	NULL
)	NULL
was	NULL
added	NULL
.	NULL

After	NULL
24	NULL
hr	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
then	NULL
lysed	NULL
with	NULL
200	NULL
wl	NULL
of	NULL
Triton	NULL
X-100	NULL
,	NULL
glycylglycine	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
25	NULL
mM	NULL
glycylglycine	NULL
[	NULL
pH	NULL
7.81	NULL
,	NULL
14	NULL
mM	NULL
MgSO	NULL
,	NULL
4mM	NULL
EGTA	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
cell	NULL
lysates	NULL
{	NULL
1.5	NULL
wl	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
100	NULL
wl	NULL
of	NULL
luciferase	NULL
assay	NULL
reagent	NULL
(	NULL
Pro-mega	NULL
}	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
using	NULL
a	NULL
biocounter	NULL
M2500	NULL
luminometer	NULL
(	NULL
Inotech	NULL
,	NULL
Zurich	NULL
)	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
determined	NULL
in	NULL
a	NULL
mixture	NULL
containing	NULL
50	NULL
wl	NULL
of	NULL
cell	NULL
extract	NULL
and	NULL
50	NULL
pl	NULL
of	NULL
a	NULL
buffer	NULL
containing	NULL
the	NULL
substrate	NULL
o-nitrophenyl	NULL
--	NULL
o-galactopyra-noside	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
until	NULL
a	NULL
yellow	NULL
color	NULL
developed	NULL
and	NULL
the	NULL
absorbance	NULL
was	NULL
determined	NULL
at	NULL
405	NULL
nm	NULL
.	NULL

These	NULL
values	NULL
were	NULL
used	NULL
to	NULL
normalize	NULL
transfection	NULL
efficiency	NULL
.	NULL

Cell	NULL
Death	NULL
Assay	NULL
293T	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
either	NULL
theempty	NULL
vector	NULL
(	NULL
1	NULL
g	NULL
)	NULL
or	NULL
pcDNA3	NULL
expression	NULL
construct	NULL
encoding	NULL
TRAMP	NULL
(	NULL
1	NULL
g	NULL
)	NULL
,	NULL
(	NULL
1	NULL
pg	NULL
)	NULL
,	NULL
or	NULL
both	NULL
.	NULL

Expression	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
on	NULL
whole-cell	NULL
extracts	NULL
.	NULL

The	NULL
ICE	NULL
family	NULL
inhibitor	NULL
zVAD-fmk	NULL
was	NULL
added	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
50	NULL
M	NULL
8	NULL
hr	NULL
after	NULL
transfection	NULL
.	NULL

At	NULL
24	NULL
hr	NULL
following	NULL
transfection	NULL
,	NULL
the	NULL
extent	NULL
of	NULL
cell	NULL
death	NULL
was	NULL
assessed	NULL
by	NULL
the	NULL
morphology	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Nuclear	NULL
DNA	NULL
degradation	NULL
was	NULL
determined	NULL
in	NULL
lysed	NULL
cells	NULL
using	NULL
a	NULL
kit	NULL
from	NULL
Boeh-ringer	NULL
(	NULL
Number	NULL
1544	NULL
675	NULL
)	NULL
that	NULL
detects	NULL
cytoplasmic	NULL
histone-associ-ated	NULL
DNA	NULL
fragments	NULL
.	NULL

Ligand	NULL
Binding	NULL
Assay	NULL
Wells	NULL
of	NULL
microtiter	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
various	NULL
receptor-Fc	NULL
constructs	NULL
at	NULL
1	NULL
pg/ml	NULL
in	NULL
PBS	NULL
{	NULL
100	NULL
ul	NULL
per	NULL
well	NULL
)	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
blocking	NULL
with	NULL
PBS	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
{	NULL
(	NULL
FCS	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
,	NULL
wells	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
PBS	NULL
containing	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
.	NULL

The	NULL
various	NULL
ligands	NULL
were	NULL
added	NULL
at	NULL
1	NULL
g/ml	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
PBS	NULL
containing	NULL
1	NULL
g/ml	NULL
BSA	NULL
for	NULL
1.5	NULL
hrat	NULL
37°C	NULL
,	NULL
and	NULL
after	NULL
four	NULL
washes	NULL
with	NULL
PBS	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
20	NULL
,	NULL
anti-tag	NULL
antibodies	NULL
(	NULL
1	NULL
pg/ml	NULL
anti-Flag	NULL
M2	NULL
for	NULL
FasL	NULL
,	NULL
TRAIL	NULL
,	NULL
and	NULL
TNF	NULL
;	NULL
anti-Myc	NULL
9E10	NULL
for	NULL
LTa1B2	NULL
)	NULL
in	NULL
PBS	NULL
containing	NULL
5	NULL
%	NULL
FCS	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
addition	NULL
of	NULL
anti-mouse	NULL
peroxidase	NULL
conjugates	NULL
,	NULL
the	NULL
peroxidase	NULL
activity	NULL
was	NULL
revealed	NULL
using	NULL
H	NULL
;	NULL
O	NULL
,	NULL
and	NULL
o-phenylenedi-amine	NULL
dihydrochloride	NULL
(	NULL
OPD	NULL
;	NULL
Sigma	NULL
)	NULL
as	NULL
substrates	NULL
.	NULL

Binding	NULL
of	NULL
anti-TRAMP	NULL
antibodies	NULL
(	NULL
1	NULL
ug/ml	NULL
!	NULL
)	NULL

to	NULL
receptor-Fc	NULL
was	NULL
detected	NULL
with	NULL
anti-rabbit	NULL
peroxidase	NULL
conjugates	NULL
.	NULL

In	NULL
Situ	NULL
Hybridization	NULL
and	NULL
FISH	NULL
Detection	NULL
The	NULL
biotinylated	NULL
full-length	NULL
cDNA	NULL
of	NULL
TRAMP	NULL
was	NULL
used	NULL
in	NULL
FISH	NULL
analysis	NULL
to	NULL
probe	NULL
normal	NULL
human	NULL
lymphocyte	NULL
metaphases	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Heng	NULL
and	NULL
Tsui	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Acknowledgments	NULL
Correspondence	NULL
should	NULL
be	NULL
addressed	NULL
to	NULL
J.	NULL
T.	NULL
We	NULL
thank	NULL
Dr.	NULL
Chris	NULL
Kamel	NULL
for	NULL
critical	NULL
reading	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
of	NULL
the	NULL
Swiss	NULL
National	NULL
Science	NULL
Foundation	NULL
and	NULL
the	NULL
TRAMP	NULL
,	NULL
an	NULL
Apoptosis-Signaling	NULL
Receptor	NULL
87	NULL
Human	NULL
Frontier	NULL
Science	NULL
Program	NULL
.	NULL

Received	NULL
October	NULL
23	NULL
,	NULL
1996	NULL
;	NULL
revised	NULL
December	NULL
2	NULL
,	NULL
1996	NULL
.	NULL

References	NULL
Banner	NULL
,	NULL
D.W.	NULL
,	NULL
D'Arcy	NULL
,	NULL
A.	NULL
,	NULL
Janes	NULL
,	NULL
W.	NULL
,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Schoenfeld	NULL
,	NULL
H.J	NULL
.	NULL

,	NULL
Broger	NULL
,	NULL
C.	NULL
,	NULL
Loetscher	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Lesslauer	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Crystal	NULL
structure	NULL
of	NULL
the	NULL
soluble	NULL
human	NULL
55	NULL
kd	NULL
TNF	NULL
receptor-human	NULL
TNFB	NULL
complex	NULL
:	NULL
implications	NULL
for	NULL
TNF	NULL
receptor	NULL
activation	NULL
.	NULL

Cell	NULL
73	NULL
,	NULL
431-445	NULL
.	NULL

Boldin	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Meft	NULL
,	NULL
I.L	NULL
.	NULL

,	NULL
Varfolomeev	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
Chumakov	NULL
,	NULL
I.	NULL
,	NULL
Shemer-avni	NULL
,	NULL
Y.	NULL
,	NULL
Camonis	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
and	NULL
Wallach	NULL
,	NULL
D.	NULL
(	NULL
1995a	NULL
)	NULL
.	NULL

Self-association	NULL
of	NULL
the	NULL
death	NULL
domains	NULL
of	NULL
the	NULL
p55	NULL
tumor	NULL
necrosis	NULL
factor	NULL
{	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
and	NULL
Fas/Apo1	NULL
prompts	NULL
signaling	NULL
for	NULL
TNF	NULL
and	NULL
Fas/Apo1	NULL
effects	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
387-391	NULL
.	NULL

Boldin	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Varfolomeev	NULL
,	NULL
E.E	NULL
.	NULL

,	NULL
Pancer	NULL
,	NULL
C.	NULL
,	NULL
Mett	NULL
,	NULL
IL	NULL
.	NULL

,	NULL
Camonis	NULL
,	NULL
J.H	NULL
.	NULL

,	NULL
and	NULL
Wallach	NULL
,	NULL
D.	NULL
(	NULL
1995b	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
protein	NULL
that	NULL
interacts	NULL
with	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
Fas/Apo1	NULL
contains	NULL
a	NULL
sequence	NULL
motif	NULL
related	NULL
to	NULL
the	NULL
death	NULL
domain	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
7795-7798	NULL
.	NULL

Boldin	NULL
,	NULL
M.P	NULL
.	NULL

,	NULL
Goncharov	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Goltsev	NULL
,	NULL
Y.V	NULL
.	NULL

,	NULL
and	NULL
Wallach	NULL
,	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Involvement	NULL
of	NULL
MACH	NULL
,	NULL
a	NULL
novel	NULL
MORT1/FADD-interacting	NULL
protease	NULL
,	NULL
in	NULL
Fas/APO-1-	NULL
and	NULL
TNF	NULL
receptor-induced	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
85	NULL
,	NULL
803-815	NULL
.	NULL

Bordier	NULL
,	NULL
C.	NULL
(	NULL
1981	NULL
)	NULL
.	NULL

Phase	NULL
separation	NULL
of	NULL
integral	NULL
membrane	NULL
proteins	NULL
in	NULL
Triton	NULL
X-114	NULL
solution	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

256	NULL
,	NULL
1604-1607	NULL
.	NULL

Bomer	NULL
,	NULL
C.	NULL
,	NULL
Martinou	NULL
,	NULL
I.	NULL
,	NULL
Mattmann	NULL
,	NULL
C.	NULL
,	NULL
Irmler	NULL
,	NULL
M.	NULL
,	NULL
Schaerer	NULL
,	NULL
E.	NULL
,	NULL
Martinou	NULL
,	NULL
J.C.	NULL
,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
bel-2	NULL
a	NULL
does	NULL
not	NULL
require	NULL
membrane	NULL
attachment	NULL
,	NULL
but	NULL
two	NULL
conserved	NULL
domains	NULL
to	NULL
suppress	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

126	NULL
,	NULL
1059-1068	NULL
.	NULL

Browning	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Ngam-ek	NULL
,	NULL
A.	NULL
,	NULL
Lawton	NULL
,	NULL
P.	NULL
,	NULL
DeMarinis	NULL
,	NULL
J.	NULL
,	NULL
Tizard	NULL
,	NULL
R.	NULL
,	NULL
Chow	NULL
,	NULL
E.P	NULL
.	NULL

,	NULL
Hession	NULL
,	NULL
C.	NULL
,	NULL
O'Brine-Greco	NULL
,	NULL
B.	NULL
,	NULL
Foley	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
and	NULL
Ware	NULL
,	NULL
C.F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Lymphotoxin	NULL
B	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
that	NULL
forms	NULL
a	NULL
heteromeric	NULL
complex	NULL
with	NULL
lymphotoxin	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Cell	NULL
72	NULL
,	NULL
847-856	NULL
.	NULL

Browning	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Miatkowski	NULL
,	NULL
K.	NULL
,	NULL
Griffiths	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
Bourdon	NULL
,	NULL
P.R	NULL
.	NULL

,	NULL
Hession	NULL
,	NULL
C.	NULL
,	NULL
Ambrose	NULL
,	NULL
C.M	NULL
.	NULL

,	NULL
and	NULL
Meier	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

Preparation	NULL
and	NULL
characterization	NULL
of	NULL
soluble	NULL
recombinant	NULL
heterotrimeric	NULL
complexes	NULL
of	NULL
human	NULL
lymphotoxins	NULL
a	NULL
and	NULL
B.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
8618-8626	NULL
.	NULL

Bucher	NULL
,	NULL
P.	NULL
,	NULL
Karplus	NULL
,	NULL
K.	NULL
,	NULL
Moeri	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hofmann	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
.	NULL

A	NULL
flexible	NULL
search	NULL
technique	NULL
based	NULL
on	NULL
generalized	NULL
profiles	NULL
.	NULL

Comput	NULL
.	NULL

Chem	NULL
.	NULL

20	NULL
,	NULL
3-24	NULL
.	NULL

Byrn	NULL
,	NULL
R.A.	NULL
,	NULL
Mordenti	NULL
,	NULL
J.	NULL
,	NULL
Lucas	NULL
,	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
D.	NULL
,	NULL
Marsters	NULL
,	NULL
S.A.	NULL
,	NULL
John-son	NULL
,	NULL
J.S	NULL
.	NULL

,	NULL
Cossum	NULL
,	NULL
P.	NULL
,	NULL
Chamow	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Wurm	NULL
,	NULL
F.M	NULL
.	NULL

,	NULL
Gregory	NULL
,	NULL
T.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
.	NULL

Biological	NULL
properties	NULL
of	NULL
a	NULL
CD4	NULL
immunoadhesin	NULL
.	NULL

Nature	NULL
344	NULL
,	NULL
667-670	NULL
.	NULL

Chinnaiyan	NULL
,	NULL
A.M.	NULL
,	NULL
Orourke	NULL
,	NULL
K.	NULL
,	NULL
Tewari	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

FADD	NULL
,	NULL
a	NULL
novel	NULL
death	NULL
domain-containing	NULL
protein	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
death	NULL
domain	NULL
of	NULL
Fas	NULL
and	NULL
initiates	NULL
apoptosis	NULL
.	NULL

Cell	NULL
81	NULL
,	NULL
505-512	NULL
.	NULL

Crowe	NULL
,	NULL
P.D	NULL
.	NULL

,	NULL
Van	NULL
Arsdale	NULL
,	NULL
T.L	NULL
.	NULL

,	NULL
Walter	NULL
,	NULL
B.N	NULL
.	NULL

,	NULL
Ware	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
Hession	NULL
,	NULL
C.	NULL
,	NULL
Ehrenfels	NULL
,	NULL
B.	NULL
,	NULL
Browning	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Din	NULL
,	NULL
W.S	NULL
.	NULL

,	NULL
Goodwin	NULL
,	NULL
R.G	NULL
.	NULL

,	NULL
and	NULL
Smith	NULL
,	NULL
C.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

A	NULL
lymphotoxin-B-specific	NULL
receptor	NULL
.	NULL

Science	NULL
264	NULL
,	NULL
707-710	NULL
.	NULL

Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
cell-death	NULL
machine	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

6	NULL
,	NULL
555-562	NULL
.	NULL

Feinstein	NULL
,	NULL
E.	NULL
,	NULL
Kimchi	NULL
,	NULL
A.	NULL
,	NULL
Wallach	NULL
,	NULL
D.	NULL
,	NULL
Boldin	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Varfolomeev	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
death	NULL
domain	NULL
:	NULL
a	NULL
module	NULL
shared	NULL
by	NULL
proteins	NULL
with	NULL
diverse	NULL
cellular	NULL
functions	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
342-344	NULL
.	NULL

Fernandesalnemri	NULL
,	NULL
T.	NULL
,	NULL
Armstrong	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
Krebs	NULL
,	NULL
J.	NULL
,	NULL
Srinivasula	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
L.	NULL
,	NULL
Bullrich	NULL
,	NULL
F.	NULL
,	NULL
Fritz	NULL
,	NULL
L.C	NULL
.	NULL

,	NULL
Trapani	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
Tomaselli	NULL
,	NULL
K.J	NULL
.	NULL

,	NULL
Lit-wack	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Alnemri	NULL
,	NULL
E.S	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

/n	NULL
vitro	NULL
activation	NULL
of	NULL
CPP32	NULL
and	NULL
Mch3	NULL
by	NULL
Mch4	NULL
,	NULL
a	NULL
novel	NULL
human	NULL
apoptotic	NULL
cysteine	NULL
protease	NULL
containing	NULL
two	NULL
FADD-like	NULL
domains	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93	NULL
,	NULL
7464-7469	NULL
.	NULL

Francis	NULL
,	NULL
M.J.	NULL
,	NULL
Hastings	NULL
,	NULL
G.Z	NULL
.	NULL

,	NULL
Brown	NULL
,	NULL
F.	NULL
,	NULL
McDermed	NULL
,	NULL
J.	NULL
,	NULL
Lu	NULL
,	NULL
Y.A	NULL
.	NULL

,	NULL
and	NULL
Tam	NULL
,	NULL
J.P.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Immunological	NULL
evaluation	NULL
of	NULL
the	NULL
multiple	NULL
antigen	NULL
peptide	NULL
(	NULL
MAP	NULL
)	NULL
system	NULL
using	NULL
the	NULL
major	NULL
immunogenic	NULL
site	NULL
of	NULL
foot-and-mouth	NULL
disease	NULL
virus	NULL
.	NULL

Immunology	NULL
73	NULL
,	NULL
249-254	NULL
.	NULL

Fuchs	NULL
,	NULL
P.	NULL
,	NULL
Strehl	NULL
,	NULL
S.	NULL
,	NULL
Dworzak	NULL
,	NULL
M.	NULL
,	NULL
Himmler	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ambros	NULL
,	NULL
P.F	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
.	NULL

Structure	NULL
of	NULL
the	NULL
human	NULL
TNF	NULL
receptor	NULL
1	NULL
(	NULL
p60	NULL
)	NULL
gene	NULL
(	NULL
TNFR1	NULL
)	NULL
and	NULL
localization	NULL
to	NULL
chromosome	NULL
12p13	NULL
.	NULL

Genomics	NULL
13	NULL
,	NULL
219-224	NULL
.	NULL

Er-ratum	NULL
:	NULL
Genomics	NULL
13	NULL
,	NULL
1384	NULL
.	NULL

Hahne	NULL
,	NULL
M.	NULL
,	NULL
Rimoldi	NULL
,	NULL
D.	NULL
,	NULL
Schroter	NULL
,	NULL
M.	NULL
,	NULL
Romero	NULL
,	NULL
P.	NULL
,	NULL
Schreier	NULL
,	NULL
M.	NULL
,	NULL
French	NULL
,	NULL
L.E	NULL
.	NULL

,	NULL
Schneider	NULL
,	NULL
P.	NULL
,	NULL
Bornand	NULL
,	NULL
T.	NULL
,	NULL
Fontana	NULL
,	NULL
A.	NULL
,	NULL
Lienard	NULL
,	NULL
D.	NULL
,	NULL
Cerottini	NULL
,	NULL
J.-C.	NULL
,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Melanoma	NULL
cells	NULL
express	NULL
Fas	NULL
(	NULL
Apo-1/CD95	NULL
)	NULL
ligand	NULL
:	NULL
implications	NULL
for	NULL
tumor	NULL
immune	NULL
escape	NULL
.	NULL

Science	NULL
274	NULL
,	NULL
1363-1366	NULL
.	NULL

Hawkins	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
and	NULL
Vaux	NULL
,	NULL
D.L	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
role	NULL
of	NULL
bel-2	NULL
in	NULL
apoptosis	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

142	NULL
,	NULL
127-139	NULL
.	NULL

Heng	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tsui	NULL
,	NULL
L.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Modes	NULL
of	NULL
DAPI	NULL
banding	NULL
and	NULL
simultaneous	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Chromosoma	NULL
102	NULL
,	NULL
325-332	NULL
.	NULL

Henkart	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

ICE	NULL
family	NULL
proteases	NULL
:	NULL
mediators	NULL
of	NULL
all	NULL
apoptotic	NULL
cell	NULL
death	NULL
?	NULL

Immunity	NULL
4	NULL
,	NULL
195-201	NULL
.	NULL

Hofmann	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
death	NULL
domain	NULL
motif	NULL
found	NULL
in	NULL
Fas	NULL
(	NULL
Apo-1	NULL
)	NULL
and	NULL
TNF	NULL
receptor	NULL
is	NULL
present	NULL
in	NULL
proteins	NULL
involved	NULL
in	NULL
apoptosis	NULL
and	NULL
axonal	NULL
guidance	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

371	NULL
,	NULL
321-323	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
Xiong	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
1-associated	NULL
protein	NULL
TRADD	NULL
signals	NULL
cell	NULL
death	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
81	NULL
,	NULL
495-504	NULL
.	NULL

Itoh	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
protein	NULL
domain	NULL
required	NULL
for	NULL
apoptosis	NULL
:	NULL
mutational	NULL
analysis	NULL
of	NULL
human	NULL
Fas	NULL
antigen	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
10932-10937	NULL
.	NULL

Itoh	NULL
,	NULL
N.	NULL
,	NULL
Yonehara	NULL
,	NULL
S.	NULL
,	NULL
Ishii	NULL
,	NULL
A.	NULL
,	NULL
Yonehara	NULL
,	NULL
M.	NULL
,	NULL
Mizushima	NULL
,	NULL
S.-I	NULL
.	NULL

,	NULL
Sameshima	NULL
,	NULL
M.	NULL
,	NULL
Hase	NULL
,	NULL
A.	NULL
,	NULL
Seto	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
poly-peptide	NULL
encoded	NULL
by	NULL
the	NULL
cDNA	NULL
for	NULL
human	NULL
cell	NULL
surface	NULL
antigen	NULL
Fas	NULL
can	NULL
mediate	NULL
apoptosis	NULL
.	NULL

Cell	NULL
66	NULL
,	NULL
233-243	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Regulators	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

17	NULL
,	NULL
101-105	NULL
.	NULL

Krammer	NULL
,	NULL
P.H	NULL
.	NULL

,	NULL
Dhein	NULL
,	NULL
J.	NULL
,	NULL
Walczak	NULL
,	NULL
H.	NULL
,	NULL
Behrmann	NULL
,	NULL
I.	NULL
,	NULL
Mariani	NULL
,	NULL
S.	NULL
,	NULL
Matiba	NULL
,	NULL
B.	NULL
,	NULL
Fath	NULL
,	NULL
M.	NULL
,	NULL
Daniel	NULL
,	NULL
P.T	NULL
.	NULL

,	NULL
Knipping	NULL
,	NULL
E.	NULL
,	NULL
Westendorp	NULL
,	NULL
M.O	NULL
.	NULL

,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
role	NULL
of	NULL
APO-1-mediated	NULL
apoptosis	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

42	NULL
,	NULL
175-191	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

ICE-like	NULL
proteases	NULL
in	NULL
apoptosis	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

20	NULL
,	NULL
198-202	NULL
.	NULL

Loetscher	NULL
,	NULL
H.	NULL
,	NULL
Pan	NULL
,	NULL
Y.C	NULL
.	NULL

,	NULL
Lahm	NULL
,	NULL
H.W	NULL
.	NULL

,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Brockhaus	NULL
,	NULL
M.	NULL
,	NULL
Tabuchi	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Lesslauer	NULL
,	NULL
W.	NULL
(	NULL
1990	NULL
)	NULL
.	NULL

Molecular	NULL
cloning	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
55	NULL
kd	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

Cell	NULL
61	NULL
,	NULL
351-359	NULL
.	NULL

Los	NULL
,	NULL
M.	NULL
,	NULL
Van	NULL
de	NULL
Craen	NULL
,	NULL
M.	NULL
,	NULL
Penning	NULL
,	NULL
L.C	NULL
.	NULL

,	NULL
Schenk	NULL
,	NULL
H.	NULL
,	NULL
Westendorp	NULL
,	NULL
M.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Droge	NULL
,	NULL
W.	NULL
,	NULL
Krammer	NULL
,	NULL
P.H	NULL
.	NULL

,	NULL
Fiers	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Schulze-Osthoff	NULL
,	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Requirement	NULL
of	NULL
an	NULL
ICE/CED-3	NULL
protease	NULL
for	NULL
Fas/	NULL
APO-1-mediated	NULL
apoptosis	NULL
.	NULL

Nature	NULL
375	NULL
,	NULL
81-83	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
Chinnaiyan	NULL
,	NULL
A.M.	NULL
,	NULL
Kischkel	NULL
,	NULL
F.C	NULL
.	NULL

,	NULL
O'Rourke	NULL
,	NULL
K.	NULL
,	NULL
Shev-chenko	NULL
,	NULL
A.	NULL
,	NULL
Ni	NULL
,	NULL
J.	NULL
,	NULL
Scaffidi	NULL
,	NULL
C.	NULL
,	NULL
Bretz	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Zhang	NULL
,	NULL
M.	NULL
,	NULL
Gentz	NULL
,	NULL
R.	NULL
,	NULL
Mann	NULL
,	NULL
M.	NULL
,	NULL
Krammer	NULL
,	NULL
P.H	NULL
.	NULL

,	NULL
Peter	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
and	NULL
Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

FLICE	NULL
,	NULL
a	NULL
novel	NULL
FADD-homologous	NULL
ICE/CED-3-like	NULL
protease	NULL
,	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
CD95	NULL
(	NULL
Fas/APO-1	NULL
)	NULL
death-inducing	NULL
signaling	NULL
complex	NULL
.	NULL

Cell	NULL
85	NULL
,	NULL
817-827	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
.	NULL

Mutations	NULL
in	NULL
the	NULL
Fas	NULL
antigen	NULL
gene	NULL
in	NULL
Ipr	NULL
mice	NULL
.	NULL

Semin	NULL
.	NULL

Immunol	NULL
.	NULL

6	NULL
,	NULL
3-8	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Golstein	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

The	NULL
Fas	NULL
death	NULL
factor	NULL
.	NULL

Science	NULL
267	NULL
,	NULL
1449-1456	NULL
.	NULL

Peitsch	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Polzar	NULL
,	NULL
B.	NULL
,	NULL
Stephan	NULL
,	NULL
H.	NULL
,	NULL
Crompton	NULL
,	NULL
T.	NULL
,	NULL
MacDonald	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Mannherz	NULL
,	NULL
H.G	NULL
.	NULL

,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
endogenous	NULL
deoxyribonuclease	NULL
involved	NULL
in	NULL
nuclear	NULL
DNA	NULL
degradation	NULL
during	NULL
apoptosis	NULL
(	NULL
programmed	NULL
cell	NULL
death	NULL
)	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
371-377	NULL
.	NULL

Pitti	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Marsters	NULL
,	NULL
S.A.	NULL
,	NULL
Ruppert	NULL
,	NULL
S.	NULL
,	NULL
Donahue	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Moore	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ashkenazi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
Apo-2	NULL
ligand	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
cytokine	NULL
family	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
12687-12690	NULL
.	NULL

Russell	NULL
,	NULL
J.H	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
.	NULL

Internal	NULL
disintegration	NULL
model	NULL
of	NULL
cytotoxic	NULL
lym-phocyte-induced	NULL
target	NULL
damage	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

72	NULL
,	NULL
97-118	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1989	NULL
)	NULL
.	NULL

Molecular	NULL
Clon-ing	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
New	NULL
York	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
)	NULL
}	NULL
.	NULL

Schroter	NULL
,	NULL
M.	NULL
,	NULL
Lowin	NULL
,	NULL
B.	NULL
,	NULL
Borner	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Tschopp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
fas	NULL
(	NULL
apo-1/cd95	NULL
)	NULL
-	NULL
and	NULL
perforin-mediated	NULL
lytic	NULL
pathways	NULL
of	NULL
Immunity	NULL
88	NULL
primary	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
by	NULL
the	NULL
protooncogene	NULL
bel-2	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
,	NULL
3509-3513	NULL
.	NULL

Smith	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Davis	NULL
,	NULL
T.	NULL
,	NULL
Wignall	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Din	NULL
,	NULL
W.S	NULL
.	NULL

,	NULL
Farrah	NULL
,	NULL
T.	NULL
,	NULL
Upton	NULL
,	NULL
C.	NULL
,	NULL
McFadden	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Goodwin	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
.	NULL

T2	NULL
open	NULL
reading	NULL
frame	NULL
from	NULL
the	NULL
Shope	NULL
fibroma	NULL
virus	NULL
encodes	NULL
a	NULL
soluble	NULL
form	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

176	NULL
,	NULL
335-342	NULL
.	NULL

Smith	NULL
,	NULL
C.A	NULL
.	NULL

,	NULL
Farrah	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Goodwin	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
:	NULL
activation	NULL
,	NULL
costimulation	NULL
,	NULL
and	NULL
death	NULL
.	NULL

Cell	NULL
76	NULL
,	NULL
959-962	NULL
.	NULL

Strasser	NULL
,	NULL
A.	NULL
,	NULL
Harris	NULL
,	NULL
A.W	NULL
.	NULL

,	NULL
Huang	NULL
,	NULL
D.C.S	NULL
.	NULL

,	NULL
Krammer	NULL
,	NULL
P.H	NULL
.	NULL

,	NULL
and	NULL
Cory	NULL
,	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
.	NULL

Bcl-2	NULL
and	NULL
Fas/Apo-1	NULL
regulate	NULL
distinct	NULL
pathways	NULL
to	NULL
lymphocyte	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
6136-6147	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.A.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
Hu	NULL
,	NULL
Y.F	NULL
.	NULL

,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
19932	NULL
)	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
's	NULL
cytotoxic	NULL
activity	NULL
is	NULL
signaled	NULL
by	NULL
the	NULL
p55	NULL
TNF	NULL
receptor	NULL
.	NULL

Cell	NULL
73	NULL
,	NULL
213-216	NULL
.	NULL

Tartaglia	NULL
,	NULL
L.A.	NULL
,	NULL
Ayres	NULL
,	NULL
T.M	NULL
.	NULL

,	NULL
Wong	NULL
,	NULL
G.H	NULL
.	NULL

,	NULL
and	NULL
Goeddel	NULL
,	NULL
D.V	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
.	NULL

A	NULL
novel	NULL
domain	NULL
within	NULL
the	NULL
55	NULL
kd	NULL
TNF	NULL
receptor	NULL
signals	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
74	NULL
,	NULL
845-853	NULL
.	NULL

Tewari	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Fas-	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-induced	NULL
apoptosis	NULL
is	NULL
inhibited	NULL
by	NULL
the	NULL
poxvirus	NULL
CrmA	NULL
gene	NULL
product	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
3255-3260	NULL
.	NULL

Upton	NULL
,	NULL
C.	NULL
,	NULL
Macen	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Schreiber	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McFadden	NULL
,	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
.	NULL

Myxoma	NULL
virus	NULL
expresses	NULL
a	NULL
secreted	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
gene	NULL
family	NULL
that	NULL
contributes	NULL
to	NULL
viral	NULL
virulence	NULL
.	NULL

Virology	NULL
184	NULL
,	NULL
370-382	NULL
.	NULL

Ware	NULL
,	NULL
C.F	NULL
.	NULL

,	NULL
Vanarsdale	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Vanarsdale	NULL
,	NULL
T.L	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Apoptosis	NULL
mediated	NULL
by	NULL
the	NULL
TNF-related	NULL
cytokine	NULL
and	NULL
receptor	NULL
families	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

60	NULL
,	NULL
47-55	NULL
.	NULL

Watanabe	NULL
,	NULL
F.R	NULL
.	NULL

,	NULL
Brannan	NULL
,	NULL
C.J	NULL
.	NULL

,	NULL
Copeland	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Jenkins	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
19923	NULL
)	NULL
.	NULL

Lymphoproliferation	NULL
disorder	NULL
in	NULL
mice	NULL
explained	NULL
by	NULL
defect	NULL
in	NULL
Fas	NULL
antigen	NULL
that	NULL
mediates	NULL
apoptosis	NULL
.	NULL

Nature	NULL
356	NULL
,	NULL
314-317	NULL
.	NULL

Watanabe	NULL
,	NULL
F.R	NULL
.	NULL

,	NULL
Brannan	NULL
,	NULL
C.1	NULL
.	NULL

,	NULL
Itoh	NULL
,	NULL
N.	NULL
,	NULL
Yonehara	NULL
,	NULL
S.	NULL
,	NULL
Copeland	NULL
,	NULL
N.G	NULL
.	NULL

,	NULL
Jenkins	NULL
,	NULL
N.A	NULL
.	NULL

,	NULL
and	NULL
Nagata	NULL
,	NULL
S.	NULL
(	NULL
1992b	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
structure	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
chromosomal	NULL
assignment	NULL
of	NULL
the	NULL
mouse	NULL
Fas	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
1274-1279	NULL
.	NULL

Wiley	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Schooley	NULL
,	NULL
K.	NULL
,	NULL
Smolak	NULL
,	NULL
P.J	NULL
.	NULL

,	NULL
Din	NULL
,	NULL
W.S	NULL
.	NULL

,	NULL
Huang	NULL
,	NULL
C.P	NULL
.	NULL

,	NULL
Ni-choll	NULL
,	NULL
J.K.	NULL
,	NULL
Sutherland	NULL
,	NULL
G.R	NULL
.	NULL

,	NULL
Smith	NULL
,	NULL
T.D	NULL
.	NULL

,	NULL
Rauch	NULL
,	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
CA	NULL
.	NULL

,	NULL
and	NULL
Goodwin	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
.	NULL

Identification	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
that	NULL
induces	NULL
apoptosis	NULL
.	NULL

Immunity	NULL
3	NULL
,	NULL
673-682	NULL
.	NULL

Wilson	NULL
,	NULL
A.	NULL
,	NULL
de	NULL
Villartay	NULL
,	NULL
J.P.	NULL
,	NULL
and	NULL
MacDonald	NULL
,	NULL
H.R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
receptor	NULL
8	NULL
gene	NULL
rearrangement	NULL
and	NULL
T	NULL
early	NULL
«	NULL
(	NULL
TEA	NULL
)	NULL
expression	NULL
in	NULL
immature	NULL
aB	NULL
lineage	NULL
thymocytes	NULL
:	NULL
implications	NULL
for	NULL
«	NULL
B/y85	NULL
lineage	NULL
commitment	NULL
.	NULL

Immunity	NULL
4	NULL
,	NULL
37-45	NULL
.	NULL

GenBank	NULL
Accession	NULL
Numbers	NULL
The	NULL
accession	NULL
numbers	NULL
for	NULL
the	NULL
two	NULL
TRAMP	NULL
cDNA	NULL
sequences	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
are	NULL
U75380	NULL
and	NULL
U75381	NULL
.	NULL

